bims-fagtap Biomed News
on Phage therapies and applications
Issue of 2026–11–08
sixty papers selected by
Luca Bolliger, lxBio



  1. Front Microbiol. 2026 ;17 1959850
      Multidrug-resistant and carbapenem-resistant Serratia marcescens (S. marcescens) infections are increasingly difficult to treat because of intrinsic and acquired antimicrobial-resistance mechanisms, limited therapeutic options, and the organism's capacity to persist within biofilms. Phage therapy has therefore emerged as a potential precision antimicrobial strategy against refractory S. marcescens infections. This narrative review critically examines the molecular basis, preclinical development, and translational potential of phage therapy targeting multidrug-resistant S. marcescens. Particular emphasis is placed on phage adsorption and receptor recognition, bacterial anti-phage defense systems, capsule- and biofilm-associated resistance, phage-encoded depolymerases, host-range limitations, phage screening and cocktail design, phage-antibiotic interactions, and available preclinical and clinical evidence. Current findings support the biological plausibility of this approach, particularly when strictly lytic phages are matched to the infecting clinical isolate and delivered locally in combination with antibiotics. However, the clinical evidence remains limited primarily to individual compassionate-use reports, and the therapeutic contribution of phages cannot be clearly distinguished from that of concomitant antibiotics, drainage procedures, or supportive care. Additional barriers include the emergence of phage resistance, variable pharmacokinetics, immune-mediated phage clearance, limited standardized susceptibility testing, and manufacturing and regulatory challenges. Future research should prioritize receptor-informed phage selection, representative clinical isolate panels, rationally designed phage cocktails, standardized pharmacokinetic and pharmacodynamic evaluation, and prospective controlled clinical studies. Precision phage therapy, engineered phages, curated phage libraries, and harmonized regulatory pathways may ultimately facilitate the transition of phage therapy from an individualized salvage intervention to a reproducible treatment strategy for multidrug-resistant S. marcescens infections.
    Keywords:  Serratia marcescens; anti-phage defense systems; clinical feasibility; multidrug resistance; phage therapy; phage–bacteria interactions
    DOI:  https://doi.org/10.3389/fmicb.2026.1959850
  2. Microbiol Res. 2026 Nov 03. pii: S0944-5013(26)00379-4. [Epub ahead of print] 128815
      
    Keywords:  Antimicrobial resistance; Bacteriophages; CRISPR-Cas; Phage therapy
    DOI:  https://doi.org/10.1016/j.micres.2026.128815
  3. Front Microbiol. 2026 ;17 1910892
      Carbapenem-resistant Acinetobacter baumannii (CRAB) is sustained by environmental persistence, genomic plasticity, biofilm-associated tolerance, and rapid adaptation under antibiotic pressure. These features constrain conventional antibiotic regimens and make CRAB a relevant test case for evolution-guided antimicrobial control. This review first synthesizes how resistance architecture and genomic plasticity sustain multidrug resistance and clinical persistence. It then evaluates bacteriophages as selective agents that can alter the adaptive routes available to bacterial populations. We distinguish direct phage-mediated killing from evolutionary steering, in which receptor-dependent escape may create collateral costs in capsule or envelope function, biofilm formation, virulence, immune evasion, or antibiotic susceptibility. Receptor-associated claims are organized into three evidence categories: direct matched phage-escape evidence, indirect receptor/function evidence, and cross-species hypotheses. Direct matched evidence is concentrated in defined capsule-associated systems and supports context-dependent trade-offs, not a universal class effect. Animal studies support activity in specific systems, whereas a case-level clinical evidence table shows heterogeneous formulations, routes, co-interventions, and escape measurements; these reports primarily establish feasibility and treatment-associated observations, not general efficacy or clinical steering. Delivery and engineering strategies, rapid molecular profiling, and mechanistic models are therefore assessed as indirect evidence or testable design hypotheses rather than as equivalent support for steering. Translation also requires product quality, co-localized exposure, and serial measurement of burden, escape, phenotype, and coverage. The central challenge is to identify, exploit, and monitor a measurable and potentially transient window of collateral vulnerability rather than assume a stable evolutionary trap.
    Keywords:  Acinetobacter baumannii; evolutionary steering; multimodal antimicrobial therapy; phage therapy; precision phage therapy
    DOI:  https://doi.org/10.3389/fmicb.2026.1910892
  4. Lett Appl Microbiol. 2026 Nov 03. pii: ovag095. [Epub ahead of print]
      Enterobacteriaceae represent a clinically challenging bacterial family owing to the global emergence of multidrug resistance. Bacteriophages, the natural predators of these bacteria, have emerged as powerful tools for detecting, targeting, and inhibiting these pathogens. This review provides a comprehensive overview of bacteriophages targeting Enterobacteriaceae hosts, focusing on their diversity, virion architecture, and the molecular determinants of host specificity. The dynamic co-evolution between bacterial defence strategies and phage counter-defences is discussed to illustrate the complexity of the phage-Enterobacteriaceae host interactions. Translational applications of Enterobacteriaceae phages, including phage therapy, engineered phages, phage-derived lysins as antimicrobials, and phage-based diagnostics for rapid and specific pathogen detection is also explored alongside their limitations including limited large-scale clinical trials, regulatory and manufacturing hurdles, and the need for robust host-range prediction and standardization. Overall, this review elaborates implications of bacteriophage-Enterobacteriaceae interactions to combat antimicrobial resistance and support the development of next-generation antibacterial therapies and diagnostics.
    Keywords:   Enterobacteriaceae ; Antimicrobial Resistance; Bacteriophage Diversity; Phage Therapy; Phage-Host Interactions
    DOI:  https://doi.org/10.1093/lambio/ovag095
  5. Front Microbiol. 2026 ;17 1899503
      Bacteriophage therapy offers a potential solution for treating multidrug-resistant Pseudomonas aeruginosa infections, especially those involving biofilms that reduce antibiotic effectiveness. However, successful in vitro results often don not lead to consistent clinical success due to various challenges. These challenges are categorized into four areas: biofilm and bacterial defenses, phage ecological limitations, host-related pharmacokinetic and pharmacodynamic issues, and manufacturing and regulatory hurdles. In biofilms, phage activity is collectively shaped by extracellular matrix composition, receptor accessibility, and biofilm spatial structure. Dense matrix components including exopolysaccharides and extracellular DNA (eDNA) form a key barrier to phage penetration, while biofilm thickness further modulates phage access to target cells. Additionally, bacterial anti-phage mechanisms and prophage resistance decrease effectiveness, particularly in genetically diverse strains. Phage cocktail effectiveness is influenced more by replication dynamics, receptor compatibility, and dosing schedule than by the number of phages. Imbalanced replication and shared receptor targets can lead to inter-phage competition, reducing biofilm clearance compared to single-phage therapy. In vivo, phage activity is affected by bacterial receptor expression, mucus, immune response, and biofilm gradients that foster resistant subpopulations. Phage-antibiotic combinations can improve outcomes, but their interactions vary from synergistic to antagonistic based on dosage, timing, and bacterial strain, with resistance resensitization effects being highly variable. Clinical development is hindered by non-standardized production, simplistic preclinical models, and inconsistent regulations, though Artificial intelligence and machine learning (AI/ML) could aid in screening and optimizing phage cocktails, limited by data quality. This review discusses advanced strategies to address these barriers, with a primary focus on engineered phages, sequential administration regimens, AI-driven therapeutic design, and standardized manufacturing practices. Overall, this work aims to inform the optimization of phage therapy and support its progression toward a mainstream clinical option for chronic, drug-resistant P. aeruginosa biofilm infections.
    Keywords:  Pseudomonas aeruginosa; biofilm; extracellular matrix; phage competition; phage therapy
    DOI:  https://doi.org/10.3389/fmicb.2026.1899503
  6. bioRxiv. 2026 Oct 28. pii: 2026.10.27.759484. [Epub ahead of print]
      In the face of rising antimicrobial resistance (AMR), phage therapy presents a promising alternative to antibiotics, but efficacy is limited by biofilms, narrow host range, and the rapid development of phage resistance. Here we present a new concept for phage-based antimicrobials: using small molecules to help phages infect and kill bacteria. Using checkerboard synergy assays, growth curves, and biofilm assays, we evaluate short- and medium-chain fatty acids (SCFAs/MCFAs) with diverse lytic phages against 18 strains of Stenotrophomonas maltophilia and extend our analysis to include more than 120 clinical isolates of Staphylococcus aureus , Enterococcus spp., and Pseudomonas aeruginosa . pH-neutral MCFAs (C6-C10) are bactericidal, do not diminish phage viability, and synergized with phages to delay or prevent phage-resistant bacterial rebound over 48 h. MCFAs lowered both attached and free bacterial biomass and were synergistic with envelope-active antibiotics (polymyxin B, ceftazidime, meropenem), supporting a mechanism involving bacterial envelope disruption. Phage-MCFA cooperativity was observed across both Gram-negative and Gram-positive bacteria: across 18 S. maltophilia strains and four lytic phages, phage-MCFA combinations were predominantly additive-to-synergistic; in 91 strains of Enterococcus spp., pH-neutral C8 produced widespread synergy with phage CAR, and enabled killing of numerous strains that were recalcitrant to phage alone, effectively expanding the functional host range of phage CAR; in 18 strains of S. aureus , effects were stoichiometry-dependent, showing both synergy and antagonism depending on the ratio of phage-to-MCFA; in 14 strains of P. aeruginosa , interactions were largely additive. Together, this work elevates MCFAs as potential therapeutic accompaniments that stabilize and broaden phage efficacy by addressing several of phage therapy's limitations at once and highlights the general potential of small molecules as phage adjuvants.
    SIGNIFICANCE: Bacteriophages (phages) offer a promising therapeutic approach against antimicrobial resistant pathogens, but they are often limited by biofilms, narrow host ranges, and phage resistance. Using multiple Stenotrophomonas maltophilia strains and lytic phages, we find that pH-neutral medium-chain fatty acids (MCFAs) enhance phage-mediated killing, reduce biofilm burden, and delay or prevent phage resistance. These benefits generalize beyond S. maltophilia : phage-MCFA interactions are broadly synergistic in Enterococcus spp., stoichiometry-dependent in Staphylococcus aureus , and largely additive in Pseudomonas aeruginosa . MCFAs also cooperate with envelope-active antibiotics and are antagonistic with translation inhibitors. Because fatty acids are inexpensive, biocompatible, and straightforward to formulate, our work establishes a practical strategy to create phage-permissive states and improve outcomes of phage, antibiotic, and phage-antibiotic therapies against high-priority infections.
    DOI:  https://doi.org/10.64898/2026.10.27.759484
  7. Appl Environ Microbiol. 2026 Nov 04. e0167526
      Pseudomonas aeruginosa is a high-priority opportunistic pathogen characterized by significant genetic plasticity and increasing multidrug resistance. Although phage-antibiotic combinations are increasingly explored to combat antimicrobial resistance, whether these interactions are synergistic or antagonistic and how different antibiotic classes influence phage replication and the subsequent development of resistance remain unclear. In this study, we examined combinations of the O-antigen-dependent phage phipa10 with amikacin (AMK), levofloxacin (LEV), or meropenem (MEM) against P. aeruginosa ZS-PA-35. At 24 h, the combinations showed antibiotic-dependent patterns of bacterial growth suppression. High concentrations of amikacin and meropenem reduced the extracellular yield of infectious phipa10. The highest tested levofloxacin concentration also reduced the recovered phage yield. Whole-genome sequencing of phage-resistant mutants showed that meropenem treatment drove large chromosomal deletions encompassing galU and hmgA, resulting in a characteristic brown pigmentation phenotype. LEV-selected isolates carried smaller deletions involving galU, whereas AMK-selected isolates shared a galU substitution. In a Galleria mellonella infection model, phipa10-antibiotic combinations improved host survival relative to either treatment alone, although the magnitude of the benefit varied across antibiotic classes. The meropenem combination yielded the highest observed survival proportion despite reduced phage yield in vitro. These results show that bacterial suppression, infectious phage yield, and resistance outcomes can diverge among the three tested antibiotic partners.IMPORTANCEPhage-antibiotic combinations may affect bacterial suppression, phage yield, and resistance-associated phenotypes differently. We compared three antibiotic partners in a single Pseudomonas aeruginosa-phage system. The observed growth, genetic, and larval survival outcomes varied across the tested treatments. Reduced phage yield did not preclude improved survival in the infection model. These observations support evaluating multiple outcomes when assessing a phage-antibiotic combination. Their broader relevance requires validation with additional isolates, phages, and antibiotics.
    Keywords:  Pseudomonas aeruginosa; phage resistance; phage therapy; phage-antibiotic synergy
    DOI:  https://doi.org/10.1128/aem.01675-26
  8. Int J Low Extrem Wounds. 2026 Nov 03. 15347346261501752
      BackgroundChronic wounds cause considerable morbidity, which is further compounded by antimicrobial resistance and biofilm formation. Bacteriophage therapy (BT) presents a promising alternative. However, issues such as host immune neutralisation and inflammatory reactions remain unresolved.MethodsThis prospective, interventional, non-randomized control study was conducted at the Institute of Medical Sciences, Banaras Hindu University, from July 2022 to February 2026. It involved 100 patients with chronic wounds (>6 weeks). It had two groups: Group I (n = 50) received bacteriophage therapy (BT), while Group II (n = 50) received conventional therapy (CT). Bacteriophages were isolated and applied topically every other day. Serum levels of IL-1β, IL-6, MMP-9, and TGF-β were measured using ELISA at baseline, immediately after therapy, and at six weeks after treatment completion. Neutralising antibodies in the BT group were measured through serum-phage interaction assays and data analysis was done.ResultsFollow-up was completed in 90% of patients. Diabetes (50%) was the most common comorbidity. The most commonly isolated bacteria were Pseudomonas aeruginosa (30%), Escherichia coli (26%), and Klebsiella pneumoniae (26%). The therapy duration was significantly shorter (P < .001) in the BT group (1.46 ± 0.63 months) than in the CT group (2.92 ± 1.02 months). Levels of IL-1β, IL-6, MMP-9, and TGF-β decreased significantly in both groups during and after treatment. Neutralising antibodies were detected in only 2 out of 45 BT patients (4.4%) with complete follow-up.ConclusionBT promoted faster wound healing without notably altering cytokine profiles. The fact that around 4.4% of patients developed neutralising antibodies, which did not interfere with healing, suggests that phage therapy can be safely applied.
    Keywords:  bacteriophage therapy; chronic wounds; inflammatory markers; neutralising antibodies
    DOI:  https://doi.org/10.1177/15347346261501752
  9. Cureus. 2026 Sep;18(9): e117264
      Alzheimer's disease (AD) is a major neurodegenerative disorder, whereas periodontitis is a highly prevalent chronic inflammatory disease that may have important systemic consequences. Increasing evidence suggests a bidirectional relationship between periodontitis and AD, with periodontal inflammation potentially contributing to cognitive decline and neurodegeneration, while cognitive and motor impairment may simultaneously worsen oral hygiene and periodontal health. This narrative review synthesizes current evidence regarding the epidemiological association, potential biological mechanisms, clinical implications, and emerging preventive and therapeutic strategies linking the two conditions. Evidence indicates that periodontitis is associated with an increased risk of cognitive impairment and AD, although causality remains unproven. Proposed mechanisms include translocation of periodontal pathogens, particularly Porphyromonas gingivalis, systemic inflammation and neuroinflammation, blood-brain barrier disruption, oxidative stress, microbiome alterations, and effects on amyloid-β and tau pathology. In patients with AD, progressive cognitive impairment can compromise oral self-care and increase dependence on caregivers, contributing to periodontal deterioration. Early periodontal assessment, individualized treatment, caregiver-supported oral hygiene, regular maintenance, and interdisciplinary care may therefore be clinically beneficial. Emerging approaches targeting periodontal pathogens, gingipains, and the oral microbiome are promising but require stronger clinical validation. Overall, maintaining periodontal health represents a potentially modifiable component of comprehensive strategies for reducing the oral and systemic burden associated with AD.
    Keywords:  alzheimer disease; cognitive dysfunction; neuroinflammation; oral microbiota; periodontitis
    DOI:  https://doi.org/10.7759/cureus.117264
  10. Microbiol Spectr. 2026 Nov 04. e0248626
      The growing burden of antimicrobial resistance underscores the need for effective alternatives to conventional antibiotics, with bacteriophage therapy representing a promising approach. However, insufficient product stability during storage and administration may reduce the delivered dose and confound assessments of clinical efficacy. Clinically approved crystalloid infusion solutions could facilitate phage preparation and administration, but their suitability for phage storage remains poorly characterized. The stability of four virulent bacteriophages targeting Pseudomonas aeruginosa or Staphylococcus aureus was evaluated in sodium chloride 0.45%, sodium chloride 0.9%, Ringer's lactate, Ringer's acetate, and saline magnesium (SM) buffer. Phage preparations containing 10⁹ plaque-forming units per mL were stored at 4°C, -20°C, or -80°C, with or without 10% glycerol, for up to 6 months. Phage infectivity was highly dependent on the phage, solution, and storage temperature. Buffered solutions generally preserved infectivity better than saline, particularly under frozen conditions. Glycerol improved stability during freezing, although the magnitude of this effect varied among phages and was most apparent in saline solutions. Storage at -80°C with glycerol provided the most consistent preservation across all four phages, with titers remaining close to baseline. Ringer's solutions supported high stability at -80°C also without glycerol. By contrast, storage at 4°C resulted in greater variability and reduced stability for several phages. These findings demonstrate that clinically approved crystalloid solutions can serve as vehicles for both phage storage and administration and suggest a need for phage-specific stability testing.
    IMPORTANCE: Reliable bacteriophage therapy requires formulations that preserve phage activity during storage and clinical administration. Yet, standardized approaches to phage formulation and storage remain lacking, and many clinical applications still rely on empirical practices rather than evidence-based pharmaceutical principles. This study addresses an important translational barrier by examining the stability of therapeutically relevant phages targeting Staphylococcus aureus and Pseudomonas aeruginosa in crystalloid solutions routinely used for intravenous administration. Comparison of distinct phages across different formulations, temperatures, and storage durations demonstrates that stability depends strongly on the individual phage and storage conditions. These findings expand the limited evidence on phage stability in clinically applicable formulations and reinforce the rationale for individual phage stability testing during product development to ensure the delivery of an active and consistent therapeutic dose.
    Keywords:  biological preservation; cryoprotective agents; crystalloid solutions; phage stability; phage storage; phage therapy
    DOI:  https://doi.org/10.1128/spectrum.02486-26
  11. J Infect Chemother. 2026 Nov 04. pii: S1341-321X(26)00217-5. [Epub ahead of print]32(12): 103119
       BACKGROUND: Individual Klebsiella phages typically exhibit narrow host ranges; novel phages must therefore continue to be isolated and characterized to assemble phage therapy cocktails. However, the determinants governing host range remain unclear.
    OBJECTIVES: To characterize five novel Klebsiella phages and examine relationships between their spot-lysis profiles and strain genotypes or host defense repertoires.
    METHODS: Five sewage-derived phages were morphologically characterized, and their complete genomes were determined. Spot lysis was assessed against 249 clinical isolates of the Klebsiella pneumoniae species complex (KpSC). Genotypes, virulence and resistance determinants, and anti-phage defense systems were identified from draft genomes using Kleborate and DefenseFinder.
    RESULTS: Two phages were Myovirus-like and three Siphovirus-like, representing novel species within Jiaodavirus and Sugarlandvirus, and the known species Slopekvirus matisse. Overall, 160 of 249 isolates (64.3%) showed spot lysis with at least one phage; ΦKpT256 produced spot lysis in 137 isolates (55.0%), comparatively broad for a single phage. Spot lysis extended across diverse K/O loci, sequence types, and virulence/resistance profiles. Although 2619 defense systems of 156 types were identified, descriptive comparison revealed no obvious one-to-one correspondence between spot-lysis patterns and individual defense systems.
    CONCLUSIONS: Spot-lysis patterns were not readily explained by the bacterial characteristics examined or by any single defense system, suggesting that additional host and phage factors may contribute. ΦKpT256 and the three Siphovirus-like phages showed differing species-level spot-lysis profiles and warrant evaluation as potential components of a KpSC-targeted phage cocktail.
    Keywords:  Anti-Phage defense systems; Bacteriophage; Klebsiella pneumoniae species complex; Phage genomics; Phage therapy
    DOI:  https://doi.org/10.1016/j.jiac.2026.103119
  12. Best Pract Res Clin Gastroenterol. 2026 Aug;pii: S1521-6918(26)00031-4. [Epub ahead of print]83 102121
      The pathogenesis of colorectal cancer (CRC) is inextricably linked to the gut microbiome. However, research has historically concentrated on the bacteriome, leaving the gut virome (predominantly composed of bacteriophages) largely unexplored as biological "dark matter". Recent advancements have illuminated the dual regulatory role of phages within the tumor microenvironment (TME), where they intricately modulate both bacterial community dynamics and host immune responses. This review synthesizes current evidence on viral dysbiosis throughout CRC progression and evaluates the translational potential of virome signatures as highly specific, non-invasive diagnostic and prognostic biomarkers. We then explore emerging virome-based interventions, including precision phage therapies, aimed at reshaping the TME and enhancing synergistic responses to conventional treatments and immunotherapy. To propel the field from correlative observations to actionable clinical applications, significant translational hurdles must be overcome. We highlight the urgent need for standardized bioinformatics pipelines to address reproducibility challenges and emphasize the utility of advanced, culture-independent methodologies like single-cell viral tagging to accurately map host-phage interaction networks. Finally, we advocate for the integration of large-animal models, such as CRC pig models, to validate the causal roles and longitudinal dynamics of the virome, ultimately bridging the gap between basic exploration and precision gastrointestinal oncology.
    Keywords:  Bacteriophages; Biomarkers; Colorectal cancer; Phage therapy; Tumor microenvironment; Virome
    DOI:  https://doi.org/10.1016/j.bpg.2026.102121
  13. Iran J Microbiol. 2026 Oct;18(5): 637-654
      The continuous evolutionary race between antibacterial innovation and antimicrobial resistance (AMR) has become one of the greatest challenges in the management of Gram-negative bacterial infections. Although numerous antibiotics and β-lactam-β-lactamase inhibitor combinations have been introduced since 2000, their clinical utility has been progressively eroded by the rapid emergence and global dissemination of resistance mechanisms, including carbapenemase production, reduced outer membrane permeability, multidrug efflux, target modification, and antibiotic-inactivating enzymes. This review provides a chronological and mechanistic overview of anti-Gram-negative antibiotic development over the past two decades while examining the parallel evolution of bacterial resistance that has limited the therapeutic lifespan of both established and newly approved agents. We critically discuss the mechanisms of action, antibacterial spectrum, pharmacological characteristics, clinical utility, and resistance determinants of recently approved antibiotics, with particular emphasis on therapeutic innovations that overcome conventional resistance barriers, including advanced β-lactam-β-lactamase inhibitor combinations, the siderophore cephalosporin cefiderocol, next-generation tetracyclines, aminoglycosides, and novel bacterial topoisomerase inhibitors. Emerging therapeutic strategies, including investigational antibacterial agents, artificial intelligence-assisted antibiotic discovery, bacteriophage therapy, and CRISPR-based antimicrobial approaches, are also reviewed as potential solutions to the growing challenge of multidrug-resistant Gram-negative pathogens. Collectively, these advances illustrate that successful antibiotic development increasingly depends on innovative target engagement, improved bacterial uptake, and resistance-informed drug design rather than incremental modification of existing scaffolds alone. Ultimately, preserving the clinical effectiveness of new antibiotics will require the integration of antimicrobial stewardship, rapid diagnostics, genomic surveillance, and mechanism-guided drug development to slow the continuing evolutionary arms race between bacterial adaptation and therapeutic innovation.
    Keywords:  Anti-bacterial agents; Antimicrobial stewardship; Beta-lactamases; Carbapenem resistance; Gram-negative bacteria; Multidrug resistance
    DOI:  https://doi.org/10.18502/ijm.v18i5.22853
  14. Int Wound J. 2026 Nov;pii: e71090. [Epub ahead of print]23(11):
      Diabetic foot ulcers (DFUs) are a serious and common complication of diabetes, primarily affecting the plantar surface and toes. They are associated with high rates of recurrence, amputation and mortality, making effective treatment strategies essential. This review explores the current landscape of offloading methods and rehabilitation wearable boots used in DFU management, with an emphasis on clinical efficacy, patient adherence and the integration of emerging technologies. Total contact casts (TCCs), the gold standard, achieve healing rates exceeding 80%-90% but face limited adoption due to discomfort, stigma, and lifestyle disruption. Meta-analyses indicate that custom orthotics may reduce ulcer recurrence by up to 50% compared with standard footwear, although the magnitude of benefit varies across studies. In contrast, recent advances in smart wearable devices, multimodal sensors, custom orthotics and AI-driven adaptive systems demonstrate potential to enhance patient compliance and therapeutic outcomes. Despite the availability of evidence-based guidelines, a significant gap persists in their consistent application in clinical settings. Bridging this gap requires the development of patient-centric solutions that integrate technological innovation with usability, comfort and accessibility. This review highlights the need and future for innovative approaches that integrate technology and design to support healing, rehabilitation, adherence and quality of life providing pathways for more effective and sustainable DFU management.
    Keywords:  diabetic foot ulcer; healing; offloading; patient adherence; rehabilitation boots
    DOI:  https://doi.org/10.1111/iwj.71090
  15. Diagn Microbiol Infect Dis. 2026 Oct 26. pii: S0732-8893(26)00460-8. [Epub ahead of print]117(1): 117709
       OBJECTIVES: Although deep tissue cultures are recommended for wound infections, swab-based cultures remain common. ESwab® is a liquid-based flocked swab with limited clinical validation in wound care. We compared concordance of tissue, ESwab®, and conventional Amies agar gel transport swab cultures and assessed ESwab®'s clinical utility.
    METHODS: We conducted a prospective observational study of patients with infected wounds at a wound clinic (May 2022-April 2024). After debridement, tissue cultures were obtained as part of standard care, followed by ESwab® and Amies swab cultures from the same sites; bone cultures were obtained when indicated. Concordance was assessed using kappa statistics. Discordant cases were classified as tissue-supported, possible ESwab®-additive, or indeterminate.
    RESULTS: Sixty-three patients were analyzed; 71.4% had diabetic foot ulcers, and 1.6% had superficial wounds. All three methods recovered identical organisms in 66.7% (95% CI, 53.7-78.0%). Overall agreement among the three methods was fair (Fleiss' κ = 0.242 95% confidence interval [CI], 0.098-0.387, P < 0.001). Agreement between ESwab® and Amies swabs was excellent (κ = 0.86, 95% CI, 0.70-1.00, P < 0.001), whereas agreement with tissue culture was poor (κ= -0.14, 95% CI, -0.33-0.041, P = 0.249). Among 21 discordant tissue-ESwab® cases, management was changed only in 1 case (4.8%; 95% CI, 0.1-23.8%). Concordance with bone culture was low (25%; 95% CI, 5.5-57.2%), with no change in management.
    CONCLUSIONS: Despite frequent discordance, swab-based and tissue or bone cultures rarely differed in clinical impact. Tissue and bone cultures remain preferred, while ESwab® may be useful when tissue sampling is infeasible.
    Keywords:  Chronic wounds; Concordance; Swab-based culture; Tissue culture; Wound infection
    DOI:  https://doi.org/10.1016/j.diagmicrobio.2026.117709
  16. Qual Health Res. 2026 Nov 05. 10497323261498123
      This study explores how chronic wounds may come to acquire their own social life as actors within the clinical care encounter and what effects the (de)personalisation of wounds may have on patients' care trajectories. Drawing on ethnographic data from specialist outpatient wound healing clinics in the United Kingdom and selected extracts from interviews with wound care clinicians, this study distinguishes three (de)personalisation practices through which wounds become separated from the patient's self and acquire social significance as actors within the care encounters: anthropomorphising, objectifying, and alienating wounds. Drawing on critical realism as an analytic orientation, the study then explains the ways in which wound (de)personalisation influences communication, clinical decision-making, and emotional work through material, relational, emotional, cultural, and organisational mechanisms that shape care trajectories within a healthcare context characterised by chronicity and scarcity.
    Keywords:  body; critical realism; depersonalisation; wound care; wounds
    DOI:  https://doi.org/10.1177/10497323261498123
  17. Int Wound J. 2026 Nov;pii: e71092. [Epub ahead of print]23(11):
      Silver-containing wound dressings are among the most widely used topical antimicrobial interventions in chronic wound management. Amid escalating antimicrobial resistance and increasing scrutiny of antiseptic stewardship, there is growing debate regarding the prevalence and clinical relevance of bacterial resistance to silver, yet the available evidence has not previously been systematically evaluated with a specific focus on chronic wound populations. This review aimed to evaluate the published evidence on the prevalence of silver resistance in bacteria isolated from chronic wounds and to summarise experimental evidence on the capacity of wound-associated isolates to acquire reduced silver susceptibility in vitro. We searched MEDLINE, Embase and Scopus in accordance with PRISMA guidelines, identifying 2190 records, of which five publications met eligibility criteria. Two publications investigating overlapping isolates were consolidated, yielding four independent datasets. Three prevalence datasets reported markedly different rates: studies from the United Kingdom and Sweden identified low phenotypic resistance (0 of 112 and 1 of 56 isolates) and sil gene prevalence (< 2% in both), while a study from Bangladesh reported substantially higher phenotypic resistance (31.5%) and sil carriage (30.9%). Regional differences in antibiotic use offer a plausible explanation but were not directly tested in any included study and concordance between genotypic and phenotypic resistance was poor throughout. Two in vitro induction studies produced divergent results by endpoint: reduced planktonic susceptibility reverted towards baseline once silver exposure was withdrawn, whereas substantial increases in biofilm eradication concentration in Pseudomonas aeruginosa persisted. Prevalence was low where examined, but three datasets from three countries cannot establish the global burden of silver resistance in chronic wounds and critical gaps remain in geographic representation, methodological standardisation and validated breakpoints. Current evidence is insufficient to support changes to guidelines or policy in either direction.
    DOI:  https://doi.org/10.1111/iwj.71092
  18. J Fish Dis. 2026 Nov 01. pii: e70315. [Epub ahead of print]
      Bacteriophage (phage) therapy is increasingly being used to control Flavobacterium psychrophilum impacts upon the health and production of salmonid aquaculture worldwide, and FpV-4 is a phage commonly utilised for the mitigation of F. psychrophilum outbreaks. While quantitative PCR (qPCR) methods are often used for quantifying F. psychrophilum, with its high-sensitivity and reproducibility offering a viable alternative to plate-based microbial quantification, there are few qPCR assays currently published for quantification of F. psychrophilum phages. We have developed and optimised a highly specific qPCR assay for FpV-4 quantification, capable of reliably detecting a minimum of seven copies. We applied the assay to intestinal content samples from FpV-4-fed rainbow trout (Oncorhynchus mykiss), showing consistent detection and quantification of the phage. This assay represents a new development for the evaluation of F. psychrophilum phage therapy, providing a fast quantification method that complements and reduces the potential uncertainty of plate-based enumeration.
    Keywords:   Flavobacterium psychrophilum ; Oncorhynchus mykiss ; aquaculture; bacterial cold water disease; bacteriophage therapy; qPCR
    DOI:  https://doi.org/10.1111/jfd.70315
  19. mSystems. 2026 Nov 06. e0115726
      Cystic fibrosis (CF) results in accumulation of mucus in the airways that promotes pathogen colonization, leading to respiratory exacerbations, lung failure, and death. The CF airway harbors a complex microbiota, including pathogens and oropharyngeal bacteria. Here, we reanalyzed 5,260 16S rRNA gene microbiota data sets to infer associations between members of the CF microbiota. We determined that pathogens are more likely to proliferate and dominate when present, while oropharyngeal bacteria are generally present at lower abundances. We found that higher diversity and increasing numbers of pairwise associations between bacteria were positively correlated with lung function. In contrast, dominance of the microbiota by pathogens was associated with loss of lung function. We determined that pathogens are largely negatively associated with each other and oropharyngeal bacteria, suggesting they are antagonistic toward other bacteria. As a first test of this hypothesis, we cultured 1,597 isolates from 96 people with CF and performed 12,542 coculture assays against eight representative pathogens and oropharyngeal bacteria, finding 23% of interactions resulted in inhibition. Among our isolates, Pseudomonas were the most inhibitory, but we observed variable activity between different isolates. We further found Pseudomonas aeruginosa isolates, even those from the same donor and time point, exhibited significant differences in their metabolome and bioactivity profiles that correlated with acquisition of mutations. Together, our results suggest that pathogens may disrupt the CF microbiota and proliferate in part through bioactive metabolite production. Furthermore, these data highlight that characterizing multiple isolates is necessary to capture the full landscape of chemically mediated interactions within microbiomes.IMPORTANCEThe cystic fibrosis (CF) airway harbors a complex microbiota, including oropharyngeal bacteria and opportunistic pathogens that establish chronic infections. We found that microbiota diversity is correlated with health and that a pathogen-dominated microbiota is associated with low lung function. We then inferred potential microbial interactions by determining abundance associations between CF genera, which suggested that pathogens antagonize other bacteria. To test this prediction, we cultured bacteria from people with CF and performed thousands of coculture assays, finding that approximately one-quarter of interactions resulted in growth inhibition. Pseudomonas broadly inhibited other members of the CF airway microbiota. However, we observed marked variability in bioactivity and metabolite profiles of Pseudomonas aeruginosa isolates, even from the same donor at the same time. Our results suggest that pathogens disrupt the CF microbiota, possibly through bioactive metabolite production, and that characterizing multiple isolates is necessary to capture the complete picture of interactions in these communities.
    Keywords:  Pseudomonas aeruginosa; antagonism; cystic fibrosis; lung microbiome; microbial ecology; microbial interactions; natural products; secondary metabolites
    DOI:  https://doi.org/10.1128/msystems.01157-26
  20. Microbiol Res. 2026 Oct 27. pii: S0944-5013(26)00360-5. [Epub ahead of print]315 128796
      Bacteriophage combination treatments, which combine the lytic activity of naturally occurring viruses (bacteriophages or phages) with other phages and chemical control agents, have emerged as promising options for managing bacterial pests of major food crops. However, antagonistic interactions between antimicrobials can occur, and investigation of the interplay between phage biocontrol agents and crop-approved antibiotics is crucial for the development of effective crop protection strategies. Here, we explore the interactions between therapeutically promising jumbo bacteriophage S13, newly isolated Burkholderia glumae phages, and crop-relevant antibiotics. We find that S13 cooperates with certain soil-derived temperate phages to improve growth suppression of B. glumae in vitro, and further experimentation reveals that unique phage-host interactions may contribute to these dynamics. Furthermore, we identify various interactions ranging from synergy to antagonism with crop-relevant antibiotics, suggesting that phage-antibiotic combination strategies require situational consideration. Toward the future development of new rice protection strategies, these findings propose phage combination treatments as an important area of research, and bring awareness to the complex interactions between phages, antibiotics, and B. glumae.
    Keywords:  Bacteriophage; Biocontrol; Burkholderia; Flagella; Jumbo phage; Panicle blight; Phage antibiotic synergy
    DOI:  https://doi.org/10.1016/j.micres.2026.128796
  21. iScience. 2026 Nov 20. 29(11): 118016
      Chronic respiratory diseases (CRDs) are characterized by excessive mucin accumulation that alters host-pathogen interactions within airway epithelia. Although bacteriophage therapy is increasingly considered as an alternative to antibiotics, it remains unclear how mucin-rich environments influence bacterial virulence and phage efficacy. Here, we show that exogenous mucin reshapes outcomes during Pseudomonas aeruginosa in epithelial cells. Mucin exposure induces transcriptional changes, increases epithelial susceptibility to bacterial cytotoxicity, and reduces bacterial adhesion and internalization. Surprisingly, mucin simultaneously enhances phage-mediated protection, preserving epithelial viability without impairing phage amplification. Moreover, prolonged bacterial exposure to mucin increases the cytotoxicity activity of cell-free secretomes, while altering the phenotypic and genotypic characteristics of phage-resistant bacteria. Together, these findings reveal that mucin-rich environments exert opposing effects on infection dynamics by increasing host vulnerability while enhancing phage-mediated control of bacterial infection. Our results highlight the mucosal environment as a key determinant of phage therapy outcomes and bacterial adaptation.
    Keywords:  Pseudomonas aeruginosa; airway epithelial cells; bacteriophage therapy; host-pathogen interactions; mucin-rich environment; phage-mediated protection
    DOI:  https://doi.org/10.1016/j.isci.2026.118016
  22. J Infect Chemother. 2026 Nov 06. pii: S1341-321X(26)00218-7. [Epub ahead of print] 103120
      Pseudomonas aeruginosa is an intrinsically resistant, opportunistic Gram-negative pathogen and a major cause of healthcare-associated infection, with a marked ability to acquire further resistance during therapy. Multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) classifications are widely used but may poorly reflect treatment difficulty, since resistant isolates may remain susceptible to other effective agents. The difficult-to-treat resistance (DTR) framework identifies non-susceptibility to a clinically relevant set of first-line agents and provides a more treatment-focused phenotypic classification; it has been adopted by Infectious Diseases Society of America (IDSA) and by the new Japanese Society of Chemotherapy/Japanese Association for Infectious Diseases (JSC/JAID) guidance, although it remains underrecognized in Japan. Four novel antipseudomonal β-lactams are now available for DTR P. aeruginosa (DTR-P): ceftolozane/tazobactam, ceftazidime/avibactam, imipenem/relebactam, and cefiderocol. The 2026 JSC/JAID guidance incorporates underlying resistance mechanisms into its approach to selecting among these agents. This review examines the evidence linking individual resistance mechanisms to expected in vitro susceptibility, emphasizing the heterogeneity of DTR isolates and the importance of direct susceptibility testing. We also summarize current epidemiology in Japan, where carbapenemase-producing isolates remain uncommon and chromosomal mechanisms predominate, and contrast this with regional differences worldwide. We then examine the practical challenges of mechanism-based antimicrobial selection, including limited access to mechanism testing and the frequent coexistence of resistance mechanisms. Finally, we review clinical outcome evidence for the four agents, noting broadly comparable efficacy across available studies but limited direct comparative evidence and no prospective evidence establishing that mechanism-guided selection improves clinical outcomes over conventional approaches in DTR-P infections.
    Keywords:  Pseudomonas aeruginosa; antimicrobial stewardship; cefiderocol; difficult-to-treat resistance; novel antipseudomonal β-lactams; resistance mechanisms
    DOI:  https://doi.org/10.1016/j.jiac.2026.103120
  23. Int J Nanomedicine. 2026 ;21 652123
       Background: Chronic wounds are a complex of interconnected issues, including biofilm-associated infection, persistent inflammation, oxidative stress, altered pH, metabolic dysfunction, proteolytic imbalance, hypoxia, vascular impairment and poor tissue regeneration. These anomalies encourage endogenous activation of smart microneedles (MNs) and prevent healing. MNs can transition from passive local medication delivery to adaptive therapy, which adjusts to the biological changes in chronic wounds.
    Methods: This review introduces an adaptive wound-interface framework to evaluate smart MN strategies for chronic wound healing. A pathology-driven approach links wound-associated cues to responsive materials, activation mechanisms, therapeutic functions, healing stages, and translational requirements. It examines ROS-, pH-, glucose-, enzyme-, bacteria-, and hypoxia-responsive systems; advanced MN architectures; and their integration with infection control, immunomodulation, vascular restoration, tissue regeneration, and stage-specific therapy.
    Results: The evidence shows a clear progression from simple drug-loaded MNs to systems in which pathological signals actively tune material degradation, catalytic activity, therapeutic release, or sequential therapy. Biofilm, chronic inflammation, vascular dysfunction, and impaired regeneration are common therapeutic targets. Endogenous triggers could be ROS, pH, glucose, and disease-related enzymes. Antibiofilm therapy, redox normalization, immune reprogramming, oxygen regulation, angiogenesis, re-epithelialization, extracellular matrix remodeling, and scar control are increasingly coordinated by compartmentalized or sequential architectures and responsive chemistries in advanced platforms. Clinically relevant activation thresholds, stimulus-response reproducibility, polymicrobial biofilms, irregular wound mechanics, sterilization, nanomaterial stability and safety, manufacturing scale-up, and regulatory translation are major challenges as functional complexity increases.
    Conclusion: Smart MNs are evolving from localized drug-delivery devices to physiologically educated therapeutic interfaces that may manage therapy time, location, and manner using the chronic wound microenvironment. Not the most responsive components, clinically viable systems will feature biologically meaningful sensing, temporally appropriate therapy, repeatable fabrication, and demonstrable benefit over current wound care. Instead of wound closure, future development should include clinically established stimulus ranges, stage-adaptive therapeutic programming, translationally practical designs, and enduring functional tissue restoration.
    Keywords:  biofilm; diabetic wounds; immunomodulation; microenvironment-responsive drug delivery; oxidative stress; stage-adaptive treatment; tissue regeneration
    DOI:  https://doi.org/10.2147/IJN.S652123
  24. J Breath Res. 2026 Nov 03.
      Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have revolutionized cystic fibrosis (CF) management, but airway infections and inflammation persist. This study evaluates longitudinal exhaled breath profiles and identifies volatile organic compounds (VOCs) that correlate with sputum bacterial load and neutrophil elastase (NE) levels during ivacaftor and/or antibiotic treatment.&#xD;Eight people with CF (pwCF) with a heterozygous R117H CFTR mutation and chronic lung infection with Pseudomonas aeruginosa (Pa) and/or Staphylococcus aureus were enrolled in a longitudinal study at St. Vincent's University Hospital in Dublin, Ireland. Breath samples and sputum samples were collected at multiple time points. Correlation analyses were performed between VOC abundances and bacterial load or NE levels.&#xD;We observed temporal changes in breath profile across the eight subjects during the ivacaftor and/or antibiotic treatment. Within Pa-infected subjects, 54 VOCs showed consistent directional Pearson correlation and at least moderate repeated measures correlation (rmcorr) coefficient (rrm) with bacterial load, including the 12 VOCs previously reported as Pa-associated markers. Similarly, within Sa-infected subjects, we identified eight VOCs that showed consistent directional correlation and at least moderate rrm with bacterial load, including four previously reported Sa-associated markers. Additionally, we identified 7 exploratory VOC candidates that consistently correlated with changes in NE levels, each demonstrating a general weak rrm across eight subjects.&#xD;This study demonstrates that breath profiles of pwCF change over time during ivacaftor and/or antibiotic treatment. Identifying specific breath VOCs whose levels correlate with Pa or Sa CFU/mL, as well as NE levels, supports further evaluation of exhaled breath VOCs as non-invasive markers for monitoring airway infection and inflammation in pwCF. &#xD.
    Keywords:  Breath Biomarker; Cystic Fibrosis; Pseudomonas aeruginosa; Staphylococcus aureus; Volatile Organic Compound
    DOI:  https://doi.org/10.1088/1752-7163/aebd12
  25. Cell Rep. 2026 Oct 31. pii: S2211-1247(26)01333-1. [Epub ahead of print]45(11): 118254
      The arbitrium system has transformed our understanding of phage biology by demonstrating that temperate phages communicate through extracellular peptides to coordinate lysis-lysogeny decisions. Initially considered a highly specific signaling pathway restricted to individual phage lineages, arbitrium communication has now been shown to extend beyond lineage boundaries in some phage systems. Recent studies have shown that non-cognate arbitrium peptides can interact with heterologous receptors, providing evidence of inter-phage crosstalk. Here, we synthesize current knowledge of the molecular basis of arbitrium signaling, the structural determinants of peptide-receptor specificity, and the potential ecological and evolutionary consequences of inter-phage communication. We suggest that arbitrium crosstalk may shape phage ecology by mediating competitive and potentially cooperative interactions within shared signaling environments. We also discuss its potential uses in engineered phage systems, synthetic biology, and microbiome engineering. Collectively, the available evidence broadens the concept of viral communication beyond lineage-specific signaling, while the ecological significance and practical applications of arbitrium crosstalk remain to be established.
    Keywords:  CP: microbiology; arbitrium signaling; bacteriophages; crosstalk; lysogeny; peptide signaling; phage communication; viral communication
    DOI:  https://doi.org/10.1016/j.celrep.2026.118254
  26. J Wound Care. 2026 Nov 02. 35(11): 1024-1032
       OBJECTIVE: The aim of this systematic review is to provide a comprehensive understanding on the effectiveness of topical insulin in the healing of diabetic foot ulcers (DFUs) in patients with diabetes in Asian countries.
    METHOD: A systematic review of both observational and randomised controlled trials evaluating insulin efficacy on DFUs-but which was limited to studies in Asian countries between 2016 and 2024-was conducted. Guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses were followed. Electronic databases including PubMed, Scopus, MEDLINE and Google Scholar were searched for studies comparing insulin interventions with standard of care or other interventions, based on specific inclusion criteria.
    RESULTS: A total of 16 relevant studies (out of 1132 on initial search) reporting on 1056 patients were included. Of the studies, eight reported wound healing rates in terms of reduction in wound size. Data on days of hospitalisation, number of dressing changes and insulin applications, quality of life, cost-effectiveness, and the psychological parameters of anxiety and depression, were not considered by any of the included studies.
    CONCLUSION: The findings of this review provide supportive evidence that insulin was an efficient adjunct for healing DFUs. The findings identified existing evidence and gaps within it that may inform future studies in other Asian countries and beyond.
    Keywords:  diabetes; diabetic foot ulcer; systematic review; topical insulin; wound; wound care; wound dressing; wound healing
    DOI:  https://doi.org/10.12968/jowc.2025.0211
  27. Front Microbiol. 2026 ;17 1964616
      Bacteriophages are being investigated as strain-selective tools for modifying intestinal microbial communities, but the evidence supporting ecological reconstruction is substantially less mature than the evidence supporting targeted bacterial depletion. This review separates current knowledge into three domains: established and emerging experimental evidence, human translational evidence, and hypotheses proposed for future testing. Human studies show that orally administered natural or engineered phages can be recovered from the gastrointestinal tract and can alter selected bacterial populations without antibiotic-like loss of overall community diversity. Preclinical studies further demonstrate targeted suppression of inflammatory Klebsiella pneumoniae in inflammatory bowel disease models, cytolytic Enterococcus faecalis in alcohol-associated liver disease, evolutionary steering of Escherichia coli, in situ bacterial genome editing, local therapeutic-protein production, and phage-probiotic cooperation. These findings do not yet establish that an integrated phage-successor-prebiotic sequence can durably reprogram a human gut ecosystem. To organize this translational gap, we use Subtract-Seed-Feed-Lock as an explicitly proposed design framework. A phage or phage-derived platform first depletes, weakens, or edits a disease-relevant bacterial strain or function; a niche-matched successor is then introduced; a selectively utilized nutrient supports that successor; and durability is assessed after treatment withdrawal. Related terms used in this review-Functional Phageability, Minimum Ecological Dose, Ecological Vacancy Window, nutrient-conditioned phagogram, ecological pharmacokinetics/pharmacodynamics (Eco-PK/PD), ecological pharmacovigilance, neurophagomic reverse translation, and microbiome-state digital twin-are hypothesis-generating operational concepts rather than validated clinical methods. Host signaling is likewise framed as predominantly indirect: phage-induced changes in bacterial abundance or function may alter lipopolysaccharide, short-chain fatty acids, indoles, bile acids, and other metabolites that subsequently engage inflammatory, barrier, hepatic, or neural pathways. The gut-brain application remains especially preliminary; targeting urdA-positive imidazole-propionate producers has not been validated with therapeutic phages. Clinical development will require reproducible good manufacturing practice, control of endotoxin and host-cell contaminants, product stability, resistance and immune-neutralization monitoring, environmental-shedding assessment, and regulatory strategies for genetically modified, dynamically updated, and multi-component products. The immediate opportunity is therefore precise microbial perturbation with evidence-matched endpoints; durable programmed reconstruction remains an experimentally testable objective.
    Keywords:  CRISPR; Eco-PK/PD; bacteriophage; dysbiosis; ecological succession; gut microbiome; pathobiont; phageome
    DOI:  https://doi.org/10.3389/fmicb.2026.1964616
  28. Front Med (Lausanne). 2026 ;13 1973954
       Background: Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections (PANDAS) are characterized by the abrupt onset of anxiety, obsessive-compulsive symptoms, tics, and other neuropsychiatric manifestations associated with Group A Streptococcus exposure. Although antimicrobial and immunomodulatory therapies are widely employed, many patients experience persistent or relapsing symptoms despite prolonged treatment. Bacteriophage therapy has not previously been reported in PANDAS and represents an experimental, pathogen-directed therapeutic approach.
    Case presentation: We report the case of an 11-year-old girl with severe refractory PANDAS characterized by obsessive-compulsive symptoms, anxiety, motor and vocal tics, emotional dysregulation, insomnia, agitation, and marked functional impairment, including school refusal. The diagnosis was supported by elevated antistreptococcal serology. The patient received several escalating interventions, including intramuscular benzathine penicillin, azithromycin, plasma exchange, intravenous immunoglobulins, psychotherapy, and aripiprazole. A clinical improvement was initially observed after penicillin administration, although the benefit was incomplete and transient. No active streptococcal isolate was available for phage susceptibility testing. On the basis of repeated antibiotic responsiveness, empirical anti-streptococcal bacteriophage therapy was initiated using Pyo Bacteriophages (Eliava biopreparation), administered twice daily for three 15-day cycles as add-on therapy, while antibiotics were maintained.
    Results: Clinical sustained improvement became evident approximately six days after initiation of bacteriophage therapy, mirroring the latency previously observed after penicillin, and was followed by sustained clinical stabilization. No adverse events were reported. Serial serological evaluation demonstrated a paradoxical increase in ASO and anti-DNase titres despite continuous neurological and psychiatric improvement.
    Conclusions: This case suggests that bacteriophage therapy may represent a plausible pathogen-directed strategy in selected patients with refractory PANDAS, particularly when a reproducible clinical response to anti-streptococcal antibiotics suggests persistent microbial involvement. More importantly, the observed dissociation between rising anti-streptococcal antibody titers and sustained clinical improvement raises the possibility that serological kinetics may not accurately reflect disease activity during effective pathogen-directed therapy. One possible explanation is that bacteriophage-induced bacterial lysis increased antigen exposure while simultaneously reducing the bacterial burden responsible for persistent immune activation. However, because bacteriophages were administered as add-on therapy in a single uncontrolled case, causality cannot be established. Prospective studies are required to determine the role of bacteriophage-based interventions in post-infectious neuroimmune disorders.
    Keywords:  PANDAS; autoimmune neuropsychiatric disorder; bacteriophage therapy; molecular mimicry; neuroinflammation; pans; phage-antibiotic synergy; streptococcus pyogenes
    DOI:  https://doi.org/10.3389/fmed.2026.1973954
  29. bioRxiv. 2026 Oct 13. pii: 2026.10.12.758625. [Epub ahead of print]
    AlcHepNet Investigators
      Cytolysin-positive Enterococcus faecalis has been implicated as a disease-associated pathobiont in alcohol-associated hepatitis, motivating development of selective bacteriophage-based strategies. However, strain-level determinants of phage susceptibility remain incompletely understood. We characterized the host range of three E. faecalis phages, ΦEf2.1, ΦEf2.2, and ΦEf2.3Ev, across 45 clinical isolates and investigated bacterial and phage factors associated with adsorption and productive infection. Isolates were characterized by whole-genome sequencing, cytolysin status, antimicrobial resistance determinants, and predicted anti-phage defense systems. Phage susceptibility was measured by efficiency of plating (EoP) and adsorption assays. Thirty-five of the 45 isolates (77.8%), including all 15 cylLs -positive isolates, were susceptible to at least one of the three phages at EoP ≥0.01. ΦEf2.1 and ΦEf2.2 showed greater activity against cylLs -positive isolates, which also carried higher burdens of predicted antimicrobial resistance determinants and anti-phage defense system types. Analysis of 367 complete E. faecalis RefSeq genomes classified the variable region of the enterococcal polysaccharide antigen ( epa ) locus into 15 recurrent architecture groups that were associated with phage-specific adsorption patterns. Efficient adsorption did not always result in productive infection, indicating additional post-adsorption barriers. AbiD emerged as a candidate factor associated with reduced ΦEf2.2 productivity, although this signal was prediction-tool dependent, while unexplained post-adsorption blocks suggest the involvement of additional uncharacterized mechanisms. These findings link naturally occurring epa architecture to phage adsorption and highlight distinct post-adsorption constraints on host range, providing a framework for rational phage selection against clinically relevant E. faecalis populations.
    DOI:  https://doi.org/10.64898/2026.10.12.758625
  30. Investig Clin Urol. 2026 Nov;67(6): 518-529
      Urinary tract infection (UTI) is a prevalent bacterial infection worldwide, complicated by high recurrence rates and increasing antimicrobial resistance (AMR). The elevated resistance rates to empirical therapies, particularly among Enterobacterales, emphasize the necessity for accurate and timely microbiological diagnostics. This review provides a comprehensive overview of the clinical microbiological diagnostic workflow for UTIs. We outline the sequential procedures from specimen collection, traditional Gram staining, and quantitative urine culture to modern identification methods, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), biochemical assays, direct MALDI-TOF MS, and multilocus sequence typing. Furthermore, we summarize the principles of diverse antimicrobial susceptibility testing (AST) methods, ranging from standard broth microdilution to automated AST systems and diffusion tests, alongside recent advances in genotypic AMR detection using multiplex polymerase chain reaction and next-generation sequencing. The complementary application of conventional phenotypic tests and rapid molecular diagnostics provides a practical clinical basis for accelerating the transition from empirical to targeted therapy. The systematic implementation of these diagnostic pipelines enhances the effectiveness of antimicrobial stewardship programs and reduces unnecessary exposure to broad-spectrum antimicrobials in clinical settings with growing multidrug-resistant pathogens. Moving forward, the continuous advancement of diagnostic techniques and the integrated interpretation of genotypic and phenotypic data will strengthen the scientific foundation for implementing precision medicine in UTI management.
    Keywords:  Drug resistance, bacterial; Microbiological techniques; Precision medicine; Urinary tract infections
    DOI:  https://doi.org/10.4111/icu.20260348
  31. Sci Prog. 2026 Oct-Dec;109(4):109(4): 368504261503221
      ObjectiveTo develop a cross-domain spatial AI framework for identifying conserved tissue-state organisation across wound healing, oral pathology, and cardiovascular tissue using spatial transcriptomic data.MethodsFour public spatial transcriptomic datasets spanning wound healing, periodontitis, oral squamous cell carcinoma, and cardiac tissue were integrated using recurrence modelling, graph-based spatial learning, fuzzy tissue-state analysis, and tensor decomposition. Cross-domain coupling, spatial fragmentation, recurrence structure, and permutation-based topological validation were evaluated.ResultsSix conserved fuzzy tissue states were identified, dominated by extracellular matrix remodelling, fibroblast/stromal activation, endothelial signalling, and inflammatory pathways. Latent embedding analysis demonstrated strong overlap between wound healing and oral domains, while cardiovascular tissue exhibited more compact spatial organisation. Across the four datasets, oral squamous cell carcinoma showed the highest fragmentation and spatial entropy. Tensor decomposition identified conserved stromal-remodelling programmes across domains. Permutation testing showed significantly higher graph modularity and lower spatial entropy relative to null distributions in all four datasets, whereas mean local recurrence was not significantly elevated in any dataset.ConclusionThe proposed framework identified conserved spatial tissue-state architecture linking wound healing, oral pathology, and cardiovascular tissue despite differences in tissue origin, pathology, and acquisition technology.SignificanceThese findings demonstrate the potential of spatial AI for investigating conserved stromal and inflammatory microenvironmental organisation across clinically related disease systems and may support spatial biology research in wound healing, oral, and systemic disease.
    Keywords:  Artificial intelligence; Cross-domain inflammatory biology; Data science; Spatial transcriptomics; wound healing–oral–cardiovascular axis
    DOI:  https://doi.org/10.1177/00368504261503221
  32. Front Microbiol. 2026 ;17 1990701
      Pseudomonas aeruginosa is a leading cause of healthcare-associated infections, especially in immunocompromised patients and individuals with cystic fibrosis (CF). P. aeruginosa commonly causes chronic infections within the respiratory tracts of patients with CF. These infections are marked by a shift from the production of acute virulence factors (secreted toxins) to colonization (biofilm formation) and persistence within the host. To better understand the transcriptomic changes that occur during this shift within the context of host-pathogen interactions, we took advantage of a whole-organism model system. Using an established Caenorhabditis elegans - P. aeruginosa colonization model, we identified genes differentially regulated during establishment of the infection of the C. elegans intestine. By comparing this transcriptomic signature to those from P. aeruginosa from CF sputum samples and an ex vivo porcine lung biofilm model, we demonstrated that Slow Killing partially recapitulates chronic lung infection. Notably, we observed the upregulation of lipid A and exopolysaccharide (Pel, alginate) biosynthetic genes within the nematode host and downregulation of acute virulence pathways including quorum-sensing, phenazine production, toxin secretion, and siderophore-mediated iron uptake. Further characterization of these differentially-regulated genes revealed key bacterial pathways, including quorum-sensing and the PhoPQ regulatory network, that impacted host survival during infection. These results demonstrate that the C. elegans Slow Killing model is a highly accessible tool for studying host-pathogen interactions and benchmark it against clinical samples.
    Keywords:  Caenorhabditis elegans; Liquid Killing; Pseudomonas aeruginosa; RNA sequencing; Slow Killing; colonization; transcriptomics
    DOI:  https://doi.org/10.3389/fmicb.2026.1990701
  33. Front Cell Infect Microbiol. 2026 ;16 1927600
      The rapid emergence of antimicrobial resistance has created an urgent need for diagnostic technologies capable of rapidly identifying resistant phenotypes and informing precision antimicrobial therapy. Conventional antimicrobial susceptibility testing methods remain clinically reliable; however, they are limited by relatively long turnaround times and restricted physiological resolution. In recent years, vibrational spectroscopy techniques have emerged as promising platforms for rapid phenotypic microbiology because they generate label-free biochemical fingerprints associated with proteins, lipids, nucleic acids, carbohydrates, and membrane biomolecules. When integrated with machine learning and artificial intelligence, these technologies could provide highly sensitive tools for rapid bacterial classification, resistance prediction, and monitoring of dynamic physiological adaptation during antibiotic exposure. This review discusses the integration of chemometrics, machine learning, and deep learning algorithms with spectroscopic datasets, emphasizing both predictive performance and biological interpretability. It is highly useful for bacterial identification, biochemical characterization, and resistance profiling across multiple microbial species. Major controversies regarding genotype-versus-phenotype diagnostics, reproducibility, standardization, and AI explainability are also examined. Finally, we highlight current research gaps and future directions, including single-cell spectroscopy, multimodal phenotyping, explainable AI frameworks, and approaches in systems microbiology. Taken together, the available evidence indicates that integrating vibrational spectroscopy with artificial intelligence could substantially reshape future antimicrobial resistance diagnostics and mechanistic microbiology.
    Keywords:  FTIR spectroscopy; antimicrobial resistance; artificial intelligence - AI; dynamic phenotyping; machine learning algorithms
    DOI:  https://doi.org/10.3389/fcimb.2026.1927600
  34. FASEB J. 2026 Nov 15. pii: e72425. [Epub ahead of print]40(21):
      The human skin microbiome is a complex network of microorganisms, including bacteria, fungi, viruses, and archaea, that exist in a mutualistic relationship with the host. These microorganisms play important roles in maintaining skin homeostasis, defense against pathogens, regulation of immune response, and antimicrobial peptide synthesis. Dysbiosis, defined as an imbalance of microbial communities, has been linked to dermatological conditions including atopic dermatitis (AD), acne, psoriasis, and chronic wounds. Despite compelling mechanistic insights, the translation of microbiome science into clinically effective therapies remains inconsistent and prematurely optimistic. Emerging therapeutic strategies aim to restore and modulate the skin microbiome with precision, thereby moving beyond conventional broad-spectrum antimicrobial approaches. These encompass probiotics, prebiotics, synbiotics, live biotherapeutic products (LBPs), bacteriophage therapy, microbiome engineering, postbiotics, microbial consortia treatment, and antimicrobial peptides that selectively target microbial communities instead of eliminating them. While these strategies are biologically plausible and have initial-phase evidence, their clinical stability, reproducibility, and scalability are uncertain. Major limitations include inter-individual variability of microbiomes, transient colonization, methodological limitations in functional profiling, and regulatory uncertainties surrounding them. This review article critically evaluates microbiome-directed dermatologic therapies at the crossroads of real therapeutic potential and translational overextension. The field is not just hype; its clinical application has advanced more rapidly than the supporting evidence base justifies. Progress in this domain requires a shift from descriptive and associative research toward mechanism-driven, precision-based interventions. Such interventions must be validated against robust clinical endpoints. By critically assessing biological plausibility, clinical evidence, and translational barriers, this review provides a balanced perspective on the field and outlines realistic pathways for its evolution into a viable therapeutic paradigm.
    Keywords:  dysbiosis; host‐microbe signaling; microbial therapeutics; microbiome engineering; skin microbiome
    DOI:  https://doi.org/10.1096/fj.202602650RR
  35. J Wound Care. 2026 Nov 02. 35(11): 969-980
      Head-to-heal wounds-particularly diabetic lower-extremity wounds-remain among the most challenging and resource-intensive problems in contemporary healthcare, with five-year recurrence rates of 40-65% and a trajectory toward amputation that is frequently driven by three interacting and often under-recognised failures: inadequate perfusion; unrecognised bacterial burden; and unaddressed biomechanical deformity. Near-infrared spectroscopy (NIRS) and bacterial autofluorescence (BAF)-two point-of-care optical imaging technologies-now permit objective, real-time characterisation of the two dominant modifiable barriers to healing: tissue oxygenation and bacterial load. PRISM (perfusion imaging, regional bacterial status, infection staging, structural correction, and maintenance and monitoring) is a structured, imaging-first algorithm that organises these technologies into a single, sequential pathway for hard-to-heal wound assessment and management. This article reviews the operating principles and clinical evidence for NIRS and BAF, expands each of the five PRISM components in a stepwise clinical description, and presents an integrated decision matrix-tree that translates combined imaging findings into actionable, point-of-care interventions. By anchoring every clinical decision in real-time imaging data rather than clinical impression alone, PRISM offers a reproducible framework for earlier identification of healing barriers, more targeted therapy, antimicrobial stewardship, objective longitudinal monitoring and limb preservation.
    Keywords:  bacterial autofluorescence; bioburden; chronic; diabetic foot ulcer; hard-to-heal; limb preservation; near-infrared spectroscopy; point-of-care imaging; tissue oxygen saturation; wound; wound care; wound dressing; wound healing
    DOI:  https://doi.org/10.12968/jowc.2026.0400
  36. Anim Microbiome. 2026 Aug 04. pii: 112. [Epub ahead of print]8(1):
       BACKGROUND: Bacteriophages (phages) are pivotal regulators of microbiome ecology and function, yet their distribution, diversity and ecological roles within the bee gut remain largely unexplored, particularly across diverse bee species and geographic regions. Here, we used a large-scale metagenomic dataset to investigate phage communities associated with seven bee species across China.
    RESULTS: We recovered 121 viral operational taxonomic units (vOTUs) from 132 bee gut metagenomes, revealing that bee gut phages are dominated by the class Caudoviricetes and include numerous previously uncharacterized viral lineages. Biogeographic analyses revealed spatial structuring of phage communities such as latitudinal diversity gradient, distance-decay relationship. Variation partitioning analysis (VPA) indicated that bee host identity explained a substantially larger proportion of community variation than environmental factors. More, functional annotation further revealed that bee gut phages encode diverse carbohydrate-active enzymes (CAZymes) potentially involved in polysaccharide metabolism, as well as multiple anti-defense systems targeting bacterial antiviral mechanisms.
    CONCLUSIONS: Our study demonstrates that bee gut phages exhibit biogeographic structuring and host specificity. In addition, phages carry diverse functional genes that may influence bacterial metabolism and host-microbe interactions. These findings provide a comprehensive framework for understanding the ecological roles of phages in the bee gut and highlight their importance in shaping tripartite interactions among phages, bacteria, and bee hosts.
    Keywords:  Anti-defense systems; Biogeography; CAZyme; Phages
    DOI:  https://doi.org/10.1186/s42523-026-00599-w
  37. Int J Low Extrem Wounds. 2026 Nov 04. 15347346261504722
      This umbrella review synthesized evidence on associations between nutritional status and DFU outcomes and on the effects of nutritional interventions on wound healing and related clinical parameters. We conducted an umbrella review of systematic reviews evaluating (1) the associations between nutritional status and DFU outcomes and (2) the effects of nutritional interventions on DFU healing and related outcomes. PubMed, Scopus, Web of Science, and Embase were searched from inception to October 2026. Ten systematic reviews were included. Poor nutritional status and micronutrient deficiencies were consistently associated with impaired healing, greater ulcer severity, and increased risks of amputation and mortality. Exploratory cross-intervention pooling showed favorable effects on ulcer healing (eOR = 1.46; 95% CI: 1.17-1.81), C-reactive protein (eG = -0.76; 95% CI: -1.15 to -0.37), glycated hemoglobin (eG = -1.59; 95% CI: -2.93 to -0.24), and ulcer area (eG = -0.99; 95% CI: -1.94 to -0.05), but not erythrocyte sedimentation rate. Poor nutritional status and micronutrient deficiencies are consistently associated with adverse DFU outcomes. Although nutritional interventions showed favorable pooled effects on selected outcomes, limited evidence certainty and heterogeneity preclude identifying a specific supplement, dose, or formulation that reliably improves DFU healing.
    Keywords:  diabetic foot ulcer; dietary; nutritional interventions; nutritional status; wound healing
    DOI:  https://doi.org/10.1177/15347346261504722
  38. Folia Microbiol (Praha). 2026 Nov 03.
      The increasing prevalence of antibiotic-resistant pathogens and recurrent, biofilm-associated, toxin-mediated, or dysbiosis-related infections has created an urgent need for strategies that complement conventional antibiotics. Broad-spectrum therapy can disrupt commensal microbiota, weaken colonization resistance, and promote opportunistic or recurrent infection. Engineered probiotics offer microbiology-based interventions that can inhibit pathogen growth, disrupt biofilms, attenuate virulence, neutralize toxins, and restore protective microbiota functions. Engineered probiotic and commensal microorganisms can also respond to pathogen- or infection-associated signals, improving therapeutic localization and specificity. This review summarizes strategies for controlling antibiotic-resistant and difficult-to-treat pathogens, including pathogen-responsive antimicrobial production, bacteriocin-, pyocin-, lysin-, and antimicrobial peptide-mediated inhibition, enzymatic biofilm degradation, anti-virulence and toxin-neutralization approaches, restoration of microbiota-mediated colonization resistance, and targeted genetic approaches for pathogen elimination or antibiotic resensitization. Representative systems against Pseudomonas aeruginosa, Clostridioides difficile, Staphylococcus aureus, Listeria monocytogenes, Streptococcus pyogenes, and resistant Enterobacteriaceae are discussed. Major translational challenges include chassis selection, genetic stability, horizontal gene transfer, biocontainment, delivery, manufacturing, regulation, and host-microbiota variability. Engineered probiotics may therefore provide selective, localized, and microbiota-preserving complements to conventional therapy.
    Keywords:  Antibiotic-resistant pathogens; Biofilm control; Difficult-to-treat infections; Engineered probiotics; Microbiota-mediated colonization resistance; Virulence attenuation
    DOI:  https://doi.org/10.1007/s12223-026-01630-y
  39. Arch Microbiol. 2026 Oct 31. pii: 35. [Epub ahead of print]209(1):
      The accessory gene regulator (agr) quorum-sensing system coordinates important aspects of Staphylococcus aureus virulence, including the expression of secreted toxins and enzymes and the transition between surface-associated and dispersal-associated behaviours. Yet, agr is not a universal binary switch: its output depends on agr type, strain background, environmental conditions, regulatory cross-talk, biofilm stage, host context, and the distribution of signalling states among individual cells. This review synthesized evidence on the molecular logic of agr, its context-dependent relationship with biofilm formation and dispersal, spatial and single-cell heterogeneity, host-pathogen interactions, and emerging anti-virulence approaches. Experimental studies demonstrate that agr signalling can promote biofilm dispersal, that disrupting biofilm organization can alter agr-regulated virulence expression, and that single-cell activation can be heterogeneous. Other findings, including direct host-signal sensing by regulatory systems in non-staphylococcal pathogens and the effects of quorum quenching in other species, are relevant comparative examples but do not establish equivalent mechanisms in S. aureus. The review therefore distinguishes direct S. aureus evidence from cross-species analogies and proposed therapeutic hypotheses. We use "communication-state engineering" as a conceptual framework for evaluating whether an intervention changes the distribution of bacterial phenotypes in a clinically favourable direction, rather than judging efficacy solely by reduced agr activity. Candidate approaches include autoinducing-peptide analogues, inhibitors of AgrA or associated regulatory nodes, natural products, microbial signalling interference, quorum-quenching enzymes, ClpP-directed anti-virulence agents, and combination treatments. Important limitations remain: much evidence is derived from in vitro systems or animal models, the effects of agr inhibition on biofilm persistence are context-dependent, and clinical benefit has not been established for agr-directed therapy. Progress requires temporally resolved biofilm assays, single-cell and spatial measurements, mechanistic controls for growth inhibition, and testing in relevant infection models.
    Keywords:   Staphylococcus aureus ; Accessory gene regulator; Anti-virulence; Autoinducing peptide; Biofilm; Quorum sensing; Single-cell heterogeneity
    DOI:  https://doi.org/10.1007/s00203-026-05296-5
  40. Front Pharmacol. 2026 ;17 1994202
      Intracellular bacterial pathogens represent one of the most formidable challenges in contemporary medicine. By exploiting host cellular niches, these organisms evade immune surveillance and withstand conventional antibiotic therapies, establishing persistent reservoirs that are difficult to eradicate. Although antibiotic combinations, host-directed interventions, and drug repurposing have shown promise, conventional discovery pipelines rarely capture the dynamic and compartmentalized nature of the intracellular environment. This review proposes a systems pharmacology framework centered on subcellular pharmacokinetic/pharmacodynamic (Sub-PK/PD) profiling to predict and optimize intracellular combination therapies. Mechanistic and translational studies of intracellular drug disposition, host-pathogen metabolism, computational combination design, and biomimetic infection models were synthesized in a targeted narrative review. Particular attention was given to spatially resolved measurements, dual ribonucleic acid (RNA) sequencing, metabolic flux analysis, machine learning, and organ-on-a-chip platforms. Pathogen-containing vacuoles, phagolysosomes, the host cytosol, lipid-rich macrophages, and tissue lesions impose distinct barriers to drug ionization, accumulation, stability, and target engagement. Persistent infection also produces reciprocal metabolic rewiring: host pathways supply carbon, nitrogen, lipids, metals, and reducing equivalents, while bacterial stress programs alter growth and antibiotic susceptibility. Integrating these processes can reveal shared metabolic bottlenecks suitable for combinations of pathogen-directed and host-directed agents. Computational models can prioritize combinations, but their predictions require validation under physiologically realistic concentration-time profiles. Linking systems biology to localized Sub-PK/PD provides a practical roadmap for designing niche-specific regimens. Such regimens could improve clearance of persistent intracellular reservoirs, reduce ineffective exposure, and limit the emergence of antimicrobial resistance.
    Keywords:  antimicrobial resistance; drug synergy; host-directed therapy; intracellular pathogens; pharmacodynamics; subcellular pharmacokinetics; systems pharmacology
    DOI:  https://doi.org/10.3389/fphar.2026.1994202
  41. Food Sci Biotechnol. 2026 Nov;35(13): 3827-3836
      Antimicrobial resistance in bacteria poses a public health challenge, highlighting the urgent need for alternative antibacterial strategies. Since phages can control bacteria through mechanisms distinct from antibiotics, they can serve as an option for controlling antibiotic-resistant strains. In this study, we isolated and characterized the lytic phage RV7 targeting Salmonella enterica serovar Bareilly. The phage specifically infected Salmonella strains belonging to serogroups C1 but did not infect strains from serogroups A, B, C2, D or E, showing serogroup-dependent infectivity. To assess practical potential, we evaluated the stability and antibacterial activity of RV7. The phage RV7 remained infective across pH 3 to 10 and up to 50 °C and effectively reduced viable Salmonella in carrot, chicken, and skim milk. Taken together, the strict C1-serotype specificity of RV7 could support epidemiological investigations to identify Salmonella contamination. In addition, its activity in food matrices suggests that RV7 could serve as a biocontrol agent.
    Keywords:  Bacteriophage; Food safety; Phage therapy; Salmonella; Serogroup
    DOI:  https://doi.org/10.1007/s10068-026-02279-6
  42. Infect Drug Resist. 2026 ;19 642597
      Nontuberculous mycobacteria (NTM) are emerging as prominent opportunistic pathogens that cause a global increase in pulmonary and extrapulmonary infections, although isolation of NTM from a clinical specimen does not by itself indicate clinically significant disease. The intrinsic resistance of many NTM species to standard antibiotics and disinfectants, attributed to a lipid-rich cell wall, robust efflux pumps, enzymatic drug inactivation, and biofilm formation, complicates both clinical management and environmental control, and resistance patterns differ substantially between species and subspecies. This narrative review, based on a structured literature search, summarizes guideline-supported antibiotic therapies for major NTM species, including the Mycobacterium avium complex (MAC) and M. abscessus, and discusses emerging and investigational approaches, such as bedaquiline, omadacycline, tedizolid, novel beta-lactam/beta-lactamase inhibitor combinations, and bacteriophage therapy, distinguishing in vitro, animal, and clinical evidence. Additionally, we examined the efficacy and limitations of high-level disinfectants including glutaraldehyde, peracetic acid, orthophthalaldehyde, and hydrogen peroxide, based mainly on laboratory studies and outbreak reports. Notably, documented failures in healthcare water systems and medical equipment are consistent with the resilience of NTM biofilms. The host microbiota, including both the pulmonary and intestinal microbiota, is another area of interest. Studies have linked microbiome composition to underlying lung disease, antimicrobial exposure, and NTM susceptibility, colonization, and treatment-related changes. However, evidence directly linking the microbiota to NTM antimicrobial resistance remains limited. Experimental findings suggest that antibiotic-induced changes in the lung microbiome may weaken colonization resistance, while alterations in the gut microbiota may influence immune responses through the gut-lung axis. The extent to which these effects contribute to NTM resistance or affect clinical outcomes remains unclear. This review considers microbiota interactions alongside antimicrobial therapy, disinfection, environmental persistence, and antibiotic selection pressure, distinguishing established practices from approaches that require further investigation. Microbiota-directed strategies therefore remain experimental.
    Keywords:  antibiotic resistance; disinfectants; dysbiosis; microbiota; nontuberculous mycobacteria
    DOI:  https://doi.org/10.2147/IDR.S642597
  43. J Am Soc Mass Spectrom. 2026 Nov 04. 37(11): 2780-2793
      Gas chromatography-mass spectrometry (GC-MS) is widely applied to wound-associated volatile organic compounds (VOCs), yet the preanalytical steps that govern its sensitivity remain poorly characterized, limiting comparison across studies of diabetic foot ulcer (DFU) infection. We benchmark a controlled solvent-based extraction workflow with direct internal-standard addition for GC-MS profiling of clinical DFU swabs. A six-compound multiclass panel (butanoic acid, 3-methyl-; 1-octen-3-ol; nonanal; 5-hepten-2-one, 6-methyl-; dimethyl disulfide; and heptane) was spiked onto sterile cotton swabs with toluene-d8 as an internal standard (IS). At day 0, diethyl ether (DE) gave the highest IS-normalized response for every analyte (F(2,6) = 12.4-131.0), most markedly for hydrogen-bond-active species. A 50% nitrogen blowdown step produced volatility-dependent enhancement the lowest enrichment in every solvent (1.0-1.9-fold), whereas high-boiling analytes exceeded 2-fold in DE. Frozen storage at -20 °C for 15 days preserved the IS-normalized response within ±20% of day 0 for most analyte-solvent combinations; hexane gave the tightest precision (mean %RSD 2.3-8.0%), whereas DE was poor for heptane (25.7%). Applied to 28 infected DFUs, the workflow returned 13 VOCs meeting combined retention index (|ΔRI| ≤35) and spectral-library (match factor ≥75) criteria, spanning fatty acids, fermentation products, host lipid-peroxidation aldehydes, phenylalanine catabolites, and palmitamide. These class-stratified preanalytical benchmarks provide an analytical baseline against which clinical wound-VOC studies can be designed and compared.
    DOI:  https://doi.org/10.1021/jasms.6c00247
  44. J Multidiscip Healthc. 2026 ;19 649357
       Background: Chronic obstructive pulmonary disease (COPD) commonly coexists with other chronic conditions, which may add to treatment burden. This mixed-methods systematic review synthesized direct and indirect evidence on treatment burden in adults with COPD and comorbidities and identified instruments used to measure it.
    Methods: We followed Joanna Briggs Institute mixed-methods methodology and PRISMA 2020. Five databases were searched from inception to 6 August 2026, with supplementary grey-literature, citation and PubMed searches. Eligible studies included adults with COPD and at least one comorbidity and reported treatment burden directly (validated patient-reported instruments or qualitative accounts) or indirectly (regimen complexity or clinical control analyzed in relation to comorbidity); the indirect criterion was refined during full-text screening. A convergent segregated narrative synthesis was performed.
    Results: Nine studies from five countries were included. One study measured patient-reported treatment burden with a validated instrument and one explored it qualitatively; two developed or validated a burden instrument, three assessed regimen complexity or medication counts, and two assessed clinical control. Most were cross-sectional. Greater comorbidity was generally associated with more complex medication regimens and poorer clinical control. In the only study measuring it directly, comorbidity and regimen complexity were associated with higher treatment burden, and social support and self-efficacy with lower burden. Qualitatively, behavior-change tasks were most burdensome. In one prospective cohort, higher regimen complexity was associated with lower medication discontinuation but more re-exacerbations and readmissions.
    Conclusion: Direct evidence on treatment burden in adults with COPD and comorbidities is scarce, and most available evidence relies on indirect indicators. Observed associations are compatible with comorbidity adding to treatment workload but cannot establish causality; because the search omitted regimen-complexity and clinical-control terms, some indirect evidence may have been missed. Prospective studies using validated patient-reported treatment-burden measures in people with COPD and multimorbidity are needed to guide multidisciplinary care.
    Keywords:  cumulative complexity model; interprofessional collaboration; medication regimen complexity; multimorbidity; patient capacity; patient workload
    DOI:  https://doi.org/10.2147/JMDH.S649357
  45. J Infect Public Health. 2026 Oct 28. pii: S1876-0341(26)00281-9. [Epub ahead of print]19(12): 103409
       BACKGROUND: Reliable determination of antimicrobial resistance (AMR) is fundamental to healthcare research and practice. High-quality research evidence is essential for guiding accurate AMR detection which, in turn, informs antimicrobial stewardship (AMS) decision-making. This scoping review is directed at a critical evaluation of the recent strategies in AMR detection across the globe.
    METHODS: Pertinent primary studies on AMR-associated strategies were identified by a comprehensive literature search on scholarly databases (PubMed, Google Scholar, and EMBASE) in accordance with the PRISMA-ScR guidelines. The final set of pertinent studies published during the last 5 years (2021-2026) included 58 studies. Subsequent analysis critically evaluated the evidence of integration of advanced technologies into AMR detection and prediction programs.
    RESULTS: Whole-genome sequencing (WGS; n = 37 articles) was the primary method for AMR screening across the included studies. Metagenomic sequencing (MGS) data was used for AMR characterization in 6 studies, while PCR/multiplex PCR was used in 10 articles. An interesting trend was the use of machine learning (ML) models for predicting AMR. Almost all studies which developed, validated and/or employed ML models (n = 21 studies) reported excellent time- and cost-efficiency, high accuracy and precision, and good concordance with conventional methods for AMR screening. Building on this synthesis, we propose the Integrated Diagnostic-Stewardship-Workforce (IDSW) model, a hypothesis-generating, five layered conceptual framework linking diagnostic innovations, workforce-mediated decision making, AMS intervention, contextual modifiers, and outcome feedback loop.
    CONCLUSION: The reviewed evidence supports the adaptation of AMR detection practices for clinical decision support systems, with potential downstream implications for technology-enhanced stewardship programs. Further, the proposed IDSW model offers a framework for guiding future research, policy making, and implementation efforts that integrate diagnostics and workforce roles, with AMS as a key downstream application.
    Keywords:  Antimicrobial resistance; Antimicrobial stewardship; Healthcare systems; Machine learning; Metagenomics; Whole-genome sequencing
    DOI:  https://doi.org/10.1016/j.jiph.2026.103409
  46. ISME Commun. 2026 Jan;6(1): ycag284
      Polymicrobial airway infections, particularly those involving Staphylococcus aureus and Pseudomonas aeruginosa, are a hallmark of severe chronic respiratory diseases such as those in people with cystic fibrosis (pwCF). Yet, the mechanisms enabling their co-existence remain poorly understood. Using a human air-liquid interface (ALI) airway model, we dissected host-pathogen and interspecies dynamics during mono- and co-infections with clinically relevant bacterial pathogens. We found that S. aureus strains exhibited distinct colonization patterns and virulence profiles, with the deletion of the agr quorum sensing locus leading to attenuated epithelial disruption. Additionally, the H1 component of P. aeruginosa's type VI secretion system was critical for competitive exclusion of S. aureus, its deletion allowing for occasional co-localization of both species. Importantly, the order of co-infection strongly influenced pathogen dominance, with prior colonization of ALI models with S. aureus enabled coexistence with P. aeruginosa, thereby mimicking clinical observations in pwCF. Our results reveal that strain-specific traits and secretion systems influence microbial competition and persistence in the airway and underscore the importance of physiologically relevant models for studying chronic infections. Moreover, they provide the foundation for exploring therapeutic strategies for polymicrobial infections that account for the colonization sequence and microbial evolution for treatment design.
    Keywords:  T6SS; agr quorum sensing; bacterial competition; cystic fibrosis; host-pathogen interactions; polymicrobial infections; virulence
    DOI:  https://doi.org/10.1093/ismeco/ycag284
  47. Front Microbiol. 2026 ;17 1988464
      Bacterial biofilms are highly structured microbial communities which allow organisms to persist under different environmental challenges such as limitation of nutrients, oxidative stress, host immune defense, and antimicrobial agents. While antimicrobial resistance (AMR) has been well recognized as a key factor contributing to treatment failure, more and more evidence reported that biofilm-associated persistence is initially caused by antimicrobial tolerance rather than genetically encoded resistance. Tolerance is a change in physiology that enables the bacterial population to persist through a temporary exposure to an antimicrobial agent, while resistance is a stable heritable alteration that confers a decreased susceptibility to an antimicrobial agent. In biofilms, the bacteria are distributed in a heterogeneous manner in different ecological niches with different metabolic activities, oxygen gradients, stress responses and nutrient accessibility. This heterogeneity gives rise to specialized subpopulations, including dormant persisters that serve as reservoirs for further evolutionary adaptation. Biofilm development results in a selective environment that allows the pressure of antimicrobial agents to induce molecular adaptation through remodelling of extracellular polymeric substance (EPS), metabolic reprogramming, oxidative stress management, quorum sensing, cyclic di-guanosine monophosphate (c-di-GMP) signaling, efflux activation, horizontal gene transfer and diversification via mutations. Such processes form a continuum of tolerance-resistance, with short-term survival processes potentially leading to the development and fixation of resistant phenotypes. Traditional antimicrobial strategies, mainly relying on planktonic susceptibility testing, fail in the resilience of biofilms, necessitating biofilm-specific therapeutic strategies. Here, we review an integrated framework that describes the way in which bacterial biofilms move from antimicrobial tolerance to resistance evolution. We focus on strategies to intercept biofilm adaptation before stable resistance is achieved, using a combination of evolutionary microbiology, molecular regulation, single-cell biology and therapeutic innovation.
    Keywords:  antibiofilm therapy; antimicrobial resistance; antimicrobial tolerance; bacterial heterogeneity; biofilm; extracellular polymeric substance (EPS); quorum sensing
    DOI:  https://doi.org/10.3389/fmicb.2026.1988464
  48. Cureus. 2026 Oct;18(10): e117443
      Periodontitis is driven less by bacterial load than by a dysbiotic subgingival microbiome acting alongside a dysregulated host response, which together destroy connective tissue and alveolar bone. This understanding has shifted attention to next-generation oral probiotics as a way to target both the microbial and inflammatory components of disease. This narrative review evaluates current evidence on next-generation oral probiotics as a precision approach to periodontal microbiome modulation, their influence on host inflammatory responses and periodontal homeostasis, and their potential to resolve dysregulated inflammation and improve clinical outcomes. We searched PubMed and Google Scholar for systematic reviews, narrative reviews, randomized clinical trials, and observational and experimental studies published between 2021 and 2026. Probiotic supplementation, particularly when combined with conventional therapy such as scaling and root planing, has shown potential to reduce periodontal inflammation and improve selected clinical parameters. Probiotics have been associated with changes in pro-inflammatory mediators, including interleukin (IL)-1β, IL-6, and tumor necrosis factor-alpha (TNF-α), and matrix metalloproteinases, while potentially promoting anti-inflammatory mechanisms involving IL-10 and the resolution of inflammation; additional effects may include modulation of oxidative stress, improved epithelial barrier function, and indirect regulation of osteoclast-mediated alveolar bone remodeling. Current evidence nonetheless remains heterogeneous in strain, dose, and protocol, with mostly short follow-up, so probiotics are best regarded as a promising adjunct that attenuates inflammation and enhances conventional therapy rather than an independent means of reversing established periodontitis. Standardized, strain-specific protocols and adequately powered long-term trials are needed.
    Keywords:  dysbiosis; host modulation therapy; immunomodulation; next-generation probiotics; oral microbiota; periodontitis; probiotics; scaling and root planing
    DOI:  https://doi.org/10.7759/cureus.117443
  49. J Cyst Fibros. 2026 Nov 06. pii: S1569-1993(26)03783-5. [Epub ahead of print]
      Aging in cystic fibrosis (CF), once a hopeful possibility, is now a celebrated reality for many and attributable to expert multidisciplinary care, persistent research efforts, and fervent advocacy. The median age of survival of people with CF (PWCF) increased dramatically with the advent of cystic fibrosis transmembrane conductance regulator modulator therapies, particularly elexacaftor/tezacaftor/ivacaftor in 2019. However, as PWCF live longer, healthy aging is susceptible to the compound impact of residual CFTR dysfunction, chronic inflammation, emerging comorbidities, complexities of chronic disease management, and psychosocial burdens. We define healthy aging as maintaining physical and mental health in adults so they can remain autonomous and independent as long as possible, while also adapting lifestyle habits to support well-being and improve overall quality of life. Lifestyle factors, such as stress, nutrition, physical activity, sleep, and treatment adherence, are known to impact health outcomes in the general population. Identifying, testing, and implementing behavioral interventions addressing these factors has the potential to augment medical advances in CF care. Although the aging population of PWCF is increasingly heterogeneous and shaped by unique individual ecosystems, lifestyle behaviors impact all patients and crosscut this diversity. As CF science continues to advance toward curative therapies, parallel CF-specific research advances on modifiable lifestyle behaviors may support healthier aging and improve health outcomes. This paper outlines the current state of knowledge, identifies critical gaps, and highlights key opportunities for future research targeting modifiable lifestyle behaviors to promote healthy aging, preserve functional independence, and improve quality of life in the growing population of adults with CF.
    Keywords:  Aging; CFTR modulator therapy; Chronic inflammation; Comorbidities; Cystic fibrosis; Modifiable behaviors; Self-management
    DOI:  https://doi.org/10.1016/j.jcf.2026.11.003
  50. Microbiol Res. 2026 Oct 29. pii: S0944-5013(26)00367-8. [Epub ahead of print]315 128803
      Staphylococcal bacteriophages with proven therapeutic efficacy in anti-staphylococcal therapy have large (~140 kb) genomes and belong to subfamily Twortvirinae. Representatives of four genera (Kayvirus, Silviavirus, Sepunavirus, and Twortvirus) are the most intensively studied and are advancing toward clinical applications. However, the functions of many of their genes remain unknown and cannot be predicted from sequence homology alone. The least explored and most diverse genomic regions are the long terminal repeats (LTRs), which comprise ~10% of the virion DNA. These regions were often omitted from early genome assemblies or misplaced in genomic maps. Only recent studies have shown that LTRs encode genes expressed immediately upon infection and involved in host takeover, genome establishment, and interactions with bacterial defense systems, highlighting their critical role in successful infection during phage therapy. This review synthesizes current knowledge on the genomic architecture, transcriptional organization, and molecular functions of LTR regions in Twortvirinae phages. By integrating comparative genomics with recent transcriptomic and phage-host interaction studies, we identify LTRs as key regulatory and evolutionary hubs in Twortvirinae biology and highlight major knowledge gaps concerning their roles in bacterial immunity and phage genome evolution. The enrichment of LTRs in targets of bacterial anti-phage defense systems, together with their dynamic evolution through gene gain, loss, and diversification, suggests a central role in phage adaptation to diverse hosts. Finally, our synthesis of available data allows us, for the first time, to infer which end of the phage genome enters the host cell first during infection.
    Keywords:  CRISPR-Cas system; Long terminal repeats; Phage therapy; Phage-host interactions; Transcriptional regulation; Twortvirinae
    DOI:  https://doi.org/10.1016/j.micres.2026.128803
  51. BMC Infect Dis. 2026 Aug 04. pii: 1925. [Epub ahead of print]26(1):
      Environmental antimicrobial resistance (AMR) is increasingly recognized as a key component of the global AMR burden and may be associated with human infectious disease outcomes through complex ecological exposure pathways. However, the overall magnitude and consistency of this relationship across environmental compartments and regions remain insufficiently quantified. This study systematically synthesized observational evidence on the association between environmental AMR contamination and human infectious disease outcomes within a global One Health framework. A systematic review and meta-analysis were conducted following PRISMA 2020 guidelines. Major databases, including PubMed/MEDLINE, Scopus, Web of Science, and Embase, were searched from January 2000 to March 2025. Eligible studies included in the review were published between 2005 and 2025. Observational studies reporting quantitative associations between environmental AMR exposure and human infectious disease outcomes were included. In total, 1,842 records were identified, and 32 studies met the inclusion criteria for meta-analysis, covering evidence from Asia, Europe, Africa, and the Americas. The pooled random-effects analysis showed that environmental AMR exposure was significantly associated with higher odds of human infectious disease outcomes (OR = 1.92, 95% CI: 1.55-2.38; p < 0.001). Subgroup analyses indicated variation across environmental compartments, with higher estimates observed in wastewater-related settings. Stronger associations were also observed in low- and middle-income countries compared with high-income countries. Overall, environmental AMR exposure shows a consistent positive association with human infectious disease outcomes across diverse settings. However, these findings represent observational associations and do not imply direct causal transmission. The results support strengthening environmental AMR surveillance and integrating environmental compartments into One Health antimicrobial resistance control strategies.
    Keywords:  Antimicrobial resistance; Environment; Infectious disease outcomes; Meta-analysis; One health; Systematic review
    DOI:  https://doi.org/10.1186/s12879-026-14138-0
  52. Cell Biochem Funct. 2026 Nov;pii: e70338. [Epub ahead of print]44(11):
      Porphyromonas gingivalis (P. gingivalis) is a keystone pathogen in periodontal dysbiosis and has been linked to multiple systemic diseases. Ferroptosis is a form of regulated cell death driven by iron-dependent lipid peroxidation, and accumulating evidence implicates it in P. gingivalis-associated tissue injury. This review examines the mechanisms and disease contexts linking P. gingivalis to ferroptosis across experimental models. In inflammatory and tissue-injury models, P. gingivalis exposure is associated with disrupted iron homeostasis, increased lipid peroxidation, and impaired antioxidant defenses. In contrast, tumor models show reduced ferroptotic sensitivity associated with P. gingivalis. These findings support a context-dependent model in which P. gingivalis may alter host-cell susceptibility to ferroptosis through direct bacterial effects and indirect changes in the microbial, inflammatory, and redox environment. This framework highlights how bacterial exposure, host-cell state, and the disease microenvironment shape ferroptotic responses and provides a basis for evaluating the mechanistic and translational significance of ferroptosis in P. gingivalis-associated diseases.
    Keywords:  Porphyromonas gingivalis; ferroptosis; iron homeostasis; lipid peroxidation; periodontitis
    DOI:  https://doi.org/10.1002/cbf.70338
  53. Nat Rev Microbiol. 2026 Nov 05.
      Porphyromonas gingivalis has long been recognized as a keystone pathogen associated with periodontal diseases and has more recently been implicated in systemic comorbidities beyond the oral cavity. However, amongst the oral microbiota, P. gingivalis has a distinctive relationship with the host, and despite possessing a repertoire of virulence factors, P. gingivalis colonization does not invariably result in adverse outcomes. Under specific ecological conditions and host immune or susceptibility states, P. gingivalis functions as a keystone pathogen, exerting an impact disproportionate to its abundance in the context of a complex polymicrobial community. Indeed, P. gingivalis-containing communities induce dysbiotic immune responses that lead to pathobiont expansion and inflammatory tissue destruction. Moreover, emerging evidence indicates that virulence in P. gingivalis is tunable in response to metabolite availability. Under nutritional limitation, cell-associated gingipain activity increases, conferring on P. gingivalis the potential to more aggressively degrade host tissues and thereby generate proteinaceous substrates for growth. In addition, P. gingivalis is adept at decoupling nutritionally favourable inflammatory responses from antimicrobial pathways. Ultimately, substrate availability and the host immune response re-equilibrate, and P. gingivalis once again becomes quiescent. In this Review, we discuss the mechanistic basis of contextual virulence regulation in P. gingivalis and its impact on host homeostasis and immune function.
    DOI:  https://doi.org/10.1038/s41579-026-01386-9
  54. J Perinat Neonatal Nurs. 2026 Nov 03.
       BACKGROUND: Neonatal pressure injuries (PIs) are typically considered postnatal events, however, case evidence shows that some lesions originate in utero and are already present at birth. Their recognition is clinically relevant because they may mimic other congenital dermatological conditions and require specific neonatal wound care strategies. Misclassification can delay appropriate care and distort quality metrics. A clear framework distinguishing prenatal from postnatal lesions is needed.
    METHODS: A JBI-guided scoping review was designed in order to identify and synthesize the available evidence on pressure injuries of intrauterine origin, focusing on etiology, clinical presentation, and wound care management. A three-step search strategy was adopted and the PRISMA 2020 flow diagram was used to document the study selection process.
    DISCUSSION: Five studies met the inclusion criteria (4 case reports and one case series), describing 7 neonates. Most cases involved preterm infants delivered by cesarean section, frequently associated with premature rupture of membranes. The main etiological factors were reduced or absent amniotic fluid and intrauterine compression, including one case related to intrauterine medical devices. According to the EPUAP/NPIAP classification, lesions ranged from Stage 1 to deep tissue injury. All cases were managed conservatively, with healing times ranging from 1 week to several months and favorable outcomes.
    IMPLICATIONS FOR RESEARCH AND PRACTICE: Increased clinical awareness and early recognition of intrauterine PIs are essential. Further research is required to establish standardized definitions, improve diagnostic accuracy, and develop neonatal-specific, evidence-based wound care protocols.
    Keywords:  congenital pressure injury; intrauterine etiopathogenesis; intrauterine medical device; neonatal wound care; premature rupture of membranes
    DOI:  https://doi.org/10.1097/JPN.0000000000000986
  55. Food Res Int. 2026 Dec 01. pii: S0963-9969(26)02660-8. [Epub ahead of print]245(Pt 5): 120972
      Bacteriophages occupy a structurally contradictory position in modern food systems. Since 2006 they have been approved in multiple jurisdictions as biocontrol agents applied directly to food, and are now routinely deployed against Listeria monocytogenes, Escherichia coli O157:H7 and Salmonella enterica. In parallel, phages are the principal vehicles of transduction, the horizontal transfer mechanism by which antimicrobial resistance genes (ARGs) and virulence determinants move between bacterial cells. Current microbiological risk assessment (MRA) frameworks resolve this asymmetrically: phage biocontrol enters quantitative models as a log-reduction term, whereas phage-mediated gene mobility is rarely represented explicitly. Current evidence suggests that this pathway now warrants explicit consideration. The discovery of lateral transduction, which mobilises chromosomal regions at frequencies orders of magnitude above classical generalised transduction, indicates that phage-mediated transfer is, in the systems where it has been measured, not a rare packaging error but a routine feature of temperate phage life cycles, although its prevalence, rates, host range and ecological importance across food-associated communities remain insufficiently resolved. Concurrently, viromics, whole-genome sequencing, proximity ligation and emerging transductomic approaches have made the food-chain phageome quantifiable for the first time. Here we argue that, to our knowledge, the phageome constitutes a largely unaddressed blind spot in microbiological risk assessment, and we set out a framework for closing it. We map phage-mediated gene mobility onto the four Codex risk-analysis steps, identify the specific omics measurements that would populate each step and specify the model structures required to propagate transduction through exposure and risk characterisation. We also propose genomic screening criteria for phage biocontrol products proportionate to their transducing capacity. We conclude that phage-aware risk assessment is now technically tractable and that the principal obstacles are the absence of standardised quantification protocols, the scarcity of transduction-frequency data in real food matrices, and the lack of model structures capable of representing gene flow rather than organism flow.
    Keywords:  Antimicrobial resistance; Bacteriophage; Machine learning; Microbiological risk assessment; Mobilome; One health; Predictive microbiology; QMRA; Transduction; Viromics
    DOI:  https://doi.org/10.1016/j.foodres.2026.120972
  56. Arch Oral Biol. 2026 Oct 26. pii: S0003-9969(26)00299-2. [Epub ahead of print]193 106791
       OBJECTIVE: This narrative, mechanism-oriented review aimed to provide an integrated overview of the molecular mechanisms underlying radiation-induced oral mucositis (RIOM) and identify potential therapeutic targets with translational and clinical relevance.
    DESIGN: Targeted literature searches were conducted in PubMed and Google Scholar from inception to September 3, 2026. Relevant literature was selected and synthesized to examine RIOM molecular mechanisms, regulatory networks, and potential therapeutic targets, with a clear distinction between direct RIOM evidence and mechanistic insights extrapolated from other diseases or experimental models. Therapeutic approaches were discussed in relation to their stage of development, clinical relevance, and limitations to clinical translation.
    RESULTS: Current evidence indicates that RIOM is driven by a complex and interconnected molecular network involving radiation-induced DNA damage and oxidative stress, inflammatory signaling amplification, diverse cell death modalities, immune and stromal dysregulation, epithelial barrier disruption, microbiota imbalance, and impaired tissue repair. By integrating these processes into a unified pathogenic framework, this review highlights the dynamic interplay between tissue injury, inflammation, and repair failure that underlies disease progression. Furthermore, emerging molecular targets involved in these pathways are mapped across the course of RIOM development.
    CONCLUSIONS: This review summarizes the key molecular mechanisms that govern the initiation and progression of RIOM and, on this basis, delineates molecular drug targets with potential translational and clinical relevance. These insights provide a conceptual framework to enhance our understanding of RIOM pathobiology and may develop more effective prevention and treatment strategies.
    Keywords:  Molecular mechanism; Radiation-induced oral mucositis; Radiotherapy; Therapeutic target
    DOI:  https://doi.org/10.1016/j.archoralbio.2026.106791
  57. J Cyst Fibros. 2026 Nov 05. pii: S1569-1993(26)03774-4. [Epub ahead of print]
      Nontuberculous mycobacteria (NTM) are respiratory pathogens associated with poor clinical outcomes in people with cystic fibrosis (pwCF). CFTR modulator therapy (CFTRm), particularly elexacaftor/tezacaftor/ivacaftor (ETI), has dramatically improved outcomes in pwCF and is associated with reductions in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. However, impact on NTM remains unclear. We conducted parallel retrospective analyses of NTM trends among pwCF from 2017-2024 using CF Foundation Patient Registry (CFFPR) Annual Reports and surveillance data from National Jewish Health (NJH) Adult CF Program. Annual surveillance rates and NTM culture positivity were evaluated. For NJH longitudinal data (2020-2025), a generalized linear mixed model was used to assess NTM positivity trends, including a random intercept for subjects to account for repeated measures and intermittent missing cultures. From 2017-2024, U.S. and NJH NTM epidemiology showed parallel trends: higher NTM positivity among pwCF with cultures before CFTRm expansion and a decline in years 2020-2021, with increased rates by 2024. NJH consistently reported higher NTM positivity among cultured pwCF, yet patient-level NTM positivity aligned closely with U.S. rates. During the study, respiratory cultures substantially decreased, from 50.3% to 30.2% nationally and from 83.5% to 46.4% at NJH. NTM positivity is stable to increasing. In adjusted models, odds of NTM positivity increased annually by 4.2% nationally and 11.4% at NJH from 2020 to 2024. These findings suggest that CFTRm use decreased NTM culture surveillance, but NTM positivity is increasing. The concordance between national and referral-center data highlights the importance of reprioritizing NTM surveillance among pwCF taking CFTRm.
    Keywords:  CFTR modulator; Cystic fibrosis; Mycobacterium abscessus; Mycobacterium avium; Nontuberculous mycobacteria
    DOI:  https://doi.org/10.1016/j.jcf.2026.10.004
  58. J Dent Res. 2026 Nov 03. 220345261493921
      This study aimed to investigate how periodontitis would alter bloodstream infections (BSIs) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). We hypothesized that periodontitis would alter the microbiological profile of BSIs, particularly the relative prevalence of viridans group streptococci (VGS), common oral bacteria frequently implicated in BSIs in allo-HSCT recipients, and other non-VGS organisms. We further investigated whether these microbiological changes were associated with clinical outcomes and alterations in VGS-specific humoral immune responses. A retrospective cohort (n = 489 patients, 2010-2020) and a prospective cohort (n = 149 patients, 2021-2022) were included for this observational study recruited from Princess Margaret Cancer Centre. Patients were categorized based on pretransplant history of periodontitis. BSIs occurring during the hospitalization period and mortality up to 1,000 days posttransplant were compared between patients with and without periodontitis. Pretransplant serum samples from the prospective cohort were analyzed for VGS-specific IgG and IgA using flow cytometry. There was no difference in the rates of BSI between groups; however, in the retrospective cohort, patients with a history of periodontitis had a higher incidence of non-VGS BSIs (76.7% vs. 56.8%, P = 0.019). A similar, though nonsignificant, trend was observed in the prospective cohort (63.4% vs. 45.8%, P = 0.16). Notably, the shift toward non-VGS BSIs was stage-dependent, increasing with advanced periodontitis in both cohorts (P = 0.009 and P = 0.025, respectively). Patients with periodontitis had almost double the risk of mortality compared to those without (retrospective: hazard ratio [HR] = 1.86; 95% confidence interval [CI] = 1.31-2.69; P < 0.001; prospective: HR = 1.82; 95% CI = 0.98-3.57; P = 0.06). Elevated VGS-specific IgG and IgA levels were observed in patients with periodontitis, with lower IgG levels correlating with VGS BSIs. History of periodontitis was associated with differences in BSI microbiology, including a higher proportion of non-VGS BSIs among patients who developed BSIs, and with poorer survival outcomes in allo-HSCT recipients.
    Keywords:  alveolar bone loss; humoral immunity; immunoglobulins; mortality; neutropenia; viridans streptococci
    DOI:  https://doi.org/10.1177/00220345261493921
  59. Medicine (Baltimore). 2026 Nov 06. 105(45): e51491
       BACKGROUND: Artificial intelligence (AI) is increasingly applied to temporomandibular disorders (TMD), particularly in imaging, diagnosis, classification, and prediction. However, the global research landscape, knowledge structure, and evolving research priorities remain insufficiently characterized. This study aimed to systematically map the development and emerging trends of AI research in TMD.
    METHODS: A total of 311 publications from 2015 to 2026 were retrieved from the Web of Science Core Collection. Bibliometric and visualization analyses were conducted using CiteSpace, VOSviewer, and R (bibliometrix) to examine publication trends, scientific collaboration, citation networks, research hotspots, and thematic evolution.
    RESULTS: Publication output increased markedly after 2019, reaching its highest level in 2025. China contributed the most publications (n = 111), followed by the United States (n = 70), South Korea (n = 45), and Turkey (n = 33), with differences in international collaboration patterns. The knowledge structure reflected interdisciplinary connections among dentistry, medical imaging, computer science, and engineering. Major research hotspots included machine learning, deep learning, magnetic resonance imaging, automated diagnosis, disease classification, and prediction. Temporal analyses revealed a shift from algorithm development toward imaging-based assessment, TMD classification, and clinically oriented predictive applications.
    CONCLUSION: AI-related TMD research has expanded rapidly, with increasing emphasis on diagnostic and predictive applications. Future research should prioritize standardized protocols, multicenter datasets, external validation, and evaluation of clinical applicability to facilitate reliable integration into TMD management.
    Keywords:  deep learning; diagnostic classification; knowledge mapping; machine learning; magnetic resonance imaging; scientific collaboration
    DOI:  https://doi.org/10.1097/MD.0000000000051491
  60. J Oral Microbiol. 2026 ;18(1): 2751863
       Background: Medication-related osteonecrosis of the jaw is a severe adverse event associated with antiresorptive, antiangiogenic and other targeted therapies. Although suppressed bone remodeling and impaired vascularity are central to its pathogenesis, these mechanisms alone do not fully explain the strong clinical associations among local trauma, infection, chronic inflammation and persistent bone exposure.
    Objective: To synthesize evidence on microbial dysbiosis, host immune dysregulation, and bone metabolic imbalance in MRONJ, and to propose an integrated osteoimmuno-microbial feedback framework.
    Design: This narrative review examined English-language clinical and experimental studies, reviews, and guidelines identified through PubMed, Web of Science, and Scopus, supplemented by reference-list screening. The final search was performed on May 31, 2026.
    Results: The reviewed evidence suggests that reduced bone turnover, impaired mucosal repair, and altered immune defense create a vulnerable local niche that permits microbial persistence and multispecies biofilm formation. Dysbiotic biofilms may sustain macrophage-associated inflammatory signaling, disturb bone homeostasis, and contribute to pyroptosis- and necroptosis-related tissue injury. These processes may form a self-perpetuating cycle of microbial colonization, inflammation, bone exposure, and impaired repair. However, microbial dysbiosis has not been established as a universal initiating event.
    Conclusions: The proposed framework may help explain progression from potentially reversible local imbalance to persistent structural osteonecrosis. It highlights potential phase-adapted strategies targeting microbial ecology, inflammatory amplification, bone repair, and tissue vitality beyond conventional infection control and debridement.
    Keywords:  Medication-related osteonecrosis of the jaw; biofilm; microbial dysbiosis; oral microbiome; osteoimmunity; osteonecrosis
    DOI:  https://doi.org/10.1080/20002297.2026.2751863